cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
BLCA	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-18.46	1.41e-54	-0.8	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-18.46	1.41e-54	-0.8	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
BLCA	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-18.12	3.74e-53	-0.78	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-18.12	3.74e-53	-0.78	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
BLCA	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-17.98	1.47e-52	-0.78	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-17.98	1.47e-52	-0.78	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
BLCA	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-17.81	7.1e-52	-0.78	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-17.81	7.1e-52	-0.78	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
BLCA	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	17.81	7.41e-52	0.77	0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	17.81	7.41e-52	0.77	0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
BLCA	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-13.67	8.34e-35	-0.72	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-13.67	8.34e-35	-0.72	-0.58	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
BLCA	cis	rs7255436	0.965	rs62117510	MIMAT0021017	hsa-miR-4999-5p	9.39	6.04e-19	0.55	0.44	HDL cholesterol;	chr19:8387729	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs28729307	MIMAT0021017	hsa-miR-4999-5p	9.39	6.04e-19	0.55	0.44	HDL cholesterol;	chr19:8387858	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.894	rs10413136	MIMAT0021017	hsa-miR-4999-5p	9.39	6.04e-19	0.55	0.44	HDL cholesterol;	chr19:8387995	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs4044435	MIMAT0021017	hsa-miR-4999-5p	9.38	6.31e-19	0.55	0.44	HDL cholesterol;	chr19:8383293	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	9.38	6.43e-19	0.55	0.44	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	9.33	9.24e-19	0.55	0.43	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.898	rs7252574	MIMAT0021017	hsa-miR-4999-5p	9.17	3.25e-18	0.54	0.43	HDL cholesterol;	chr19:8376895	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	9.15	3.78e-18	0.53	0.43	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.931	rs7249520	MIMAT0021017	hsa-miR-4999-5p	9.15	3.81e-18	0.53	0.43	HDL cholesterol;	chr19:8381172	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs7249624	MIMAT0021017	hsa-miR-4999-5p	9.15	3.81e-18	0.53	0.43	HDL cholesterol;	chr19:8381251	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.83	rs4350678	MIMAT0021017	hsa-miR-4999-5p	9.15	3.81e-18	0.53	0.43	HDL cholesterol;	chr19:8382482	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	9.15	3.83e-18	0.53	0.43	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	9.15	3.83e-18	0.53	0.43	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	9.15	3.83e-18	0.53	0.43	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
BLCA	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	9.14	3.99e-18	0.53	0.43	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
BLCA	cis	rs7255436	1	rs7255436	MIMAT0021017	hsa-miR-4999-5p	9.13	4.17e-18	0.53	0.43	HDL cholesterol;	chr19:8368312	chr19:8389340~8389360:-
BLCA	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	7.59	2.55e-13	0.61	0.36	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
BLCA	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-7.07	7.47e-12	-0.54	-0.34	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-7.07	7.47e-12	-0.54	-0.34	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
BLCA	cis	rs2069426	0.778	rs662463	MIMAT0000089	hsa-miR-31-5p	-6.79	4.27e-11	-0.53	-0.33	Acute lymphoblastic leukemia (childhood);	chr9:22030439	chr9:21512158~21512178:-
BLCA	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-6.79	4.37e-11	-0.52	-0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-6.79	4.37e-11	-0.52	-0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
BLCA	cis	rs2069426	0.778	rs662463	MIMAT0004504	hsa-miR-31-3p	-6.78	4.75e-11	-0.53	-0.33	Acute lymphoblastic leukemia (childhood);	chr9:22030439	chr9:21512121~21512142:-
BLCA	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-6.67	9.2e-11	-0.52	-0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-6.67	9.2e-11	-0.52	-0.33	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
BLCA	cis	rs1867631	0.585	rs9787219	MIMAT0014979	hsa-miR-3117-3p	-6.65	1.03e-10	-0.37	-0.32	Menopause (age at onset);	chr1:66614476	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs11208922	MIMAT0014979	hsa-miR-3117-3p	-6.65	1.03e-10	-0.37	-0.32	Menopause (age at onset);	chr1:66614543	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs4655642	MIMAT0014979	hsa-miR-3117-3p	-6.53	2.19e-10	-0.37	-0.32	Menopause (age at onset);	chr1:66624400	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs12062570	MIMAT0014979	hsa-miR-3117-3p	-6.52	2.25e-10	-0.37	-0.32	Menopause (age at onset);	chr1:66620602	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-6.52	2.26e-10	-0.37	-0.32	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs5008753	MIMAT0014979	hsa-miR-3117-3p	-6.51	2.37e-10	-0.37	-0.32	Menopause (age at onset);	chr1:66626565	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-6.49	2.71e-10	-0.27	-0.32	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-6.49	2.71e-10	-0.27	-0.32	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-6.47	3.1e-10	-0.27	-0.32	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-6.47	3.1e-10	-0.27	-0.32	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-6.45	3.54e-10	-0.27	-0.32	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-6.44	3.6e-10	-0.27	-0.32	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-6.43	3.96e-10	-0.27	-0.31	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-6.42	4.01e-10	-0.27	-0.31	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-6.4	4.66e-10	-0.27	-0.31	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-6.37	5.42e-10	-0.27	-0.31	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-6.37	5.42e-10	-0.27	-0.31	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-6.37	5.42e-10	-0.27	-0.31	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	6.34	6.59e-10	0.27	0.31	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-6.33	7.08e-10	-0.27	-0.31	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-6.32	7.44e-10	-0.27	-0.31	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-6.31	7.68e-10	-0.27	-0.31	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
BLCA	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-6.29	9.08e-10	-0.36	-0.31	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
BLCA	cis	rs75358501	1	rs75358501	MIMAT0014995	hsa-miR-3130-5p	-6.26	1.04e-09	-0.53	-0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783276~206783296:-
BLCA	cis	rs75358501	1	rs75358501	MIMAT0014995_1	hsa-miR-3130-5p	-6.26	1.04e-09	-0.53	-0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206713131	chr2:206783246~206783266:+
BLCA	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-6.26	1.07e-09	-0.27	-0.31	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-6.26	1.07e-09	-0.27	-0.31	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.576	rs1338200	MIMAT0014979	hsa-miR-3117-3p	-6.23	1.24e-09	-0.39	-0.31	Presence of antiphospholipid antibodies;	chr1:66526514	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-6.23	1.24e-09	-0.27	-0.31	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-6.23	1.24e-09	-0.27	-0.31	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-6.23	1.24e-09	-0.27	-0.31	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-6.2	1.49e-09	-0.27	-0.3	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-6.2	1.49e-09	-0.27	-0.3	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-6.2	1.49e-09	-0.27	-0.3	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-6.19	1.56e-09	-0.27	-0.3	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-6.19	1.56e-09	-0.27	-0.3	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.576	rs7354983	MIMAT0014979	hsa-miR-3117-3p	-6.19	1.59e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66522466	chr1:66628485~66628505:+
BLCA	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	6.17	1.78e-09	0.4	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
BLCA	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	6.17	1.78e-09	0.4	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
BLCA	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.9e-09	-0.27	-0.3	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
BLCA	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.9e-09	-0.27	-0.3	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.9e-09	-0.27	-0.3	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.9e-09	-0.27	-0.3	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-6.16	1.9e-09	-0.27	-0.3	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.576	rs2859914	MIMAT0014979	hsa-miR-3117-3p	-6.13	2.18e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66524157	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-6.13	2.28e-09	-0.27	-0.3	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-6.12	2.4e-09	-0.26	-0.3	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-6.12	2.4e-09	-0.26	-0.3	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-6.12	2.4e-09	-0.26	-0.3	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-6.12	2.4e-09	-0.26	-0.3	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-6.12	2.4e-09	-0.26	-0.3	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.634	rs994396	MIMAT0014979	hsa-miR-3117-3p	-6.12	2.41e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66546553	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.674	rs4134135	MIMAT0014979	hsa-miR-3117-3p	-6.12	2.41e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66547045	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.535	rs6588204	MIMAT0014979	hsa-miR-3117-3p	-6.11	2.54e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66525325	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs6670827	MIMAT0014979	hsa-miR-3117-3p	-6.1	2.58e-09	-0.35	-0.3	Menopause (age at onset);	chr1:66661323	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	6.1	2.63e-09	0.19	0.3	Migraine;	chr10:103263177	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.649	rs6691033	MIMAT0014979	hsa-miR-3117-3p	-6.09	2.73e-09	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66541746	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.576	rs6588203	MIMAT0014979	hsa-miR-3117-3p	-6.09	2.78e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66525168	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.576	rs7355221	MIMAT0014979	hsa-miR-3117-3p	-6.06	3.28e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66520618	chr1:66628485~66628505:+
BLCA	cis	rs75358501	0.636	rs888621	MIMAT0014994	hsa-miR-3130-3p	-6.06	3.31e-09	-0.39	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783245~206783265:-
BLCA	cis	rs75358501	0.636	rs888621	MIMAT0014994_1	hsa-miR-3130-3p	-6.06	3.31e-09	-0.39	-0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783277~206783297:+
BLCA	cis	rs75358501	0.636	rs3815686	MIMAT0014994	hsa-miR-3130-3p	6.04	3.63e-09	0.4	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783245~206783265:-
BLCA	cis	rs75358501	0.636	rs3815686	MIMAT0014994_1	hsa-miR-3130-3p	6.04	3.63e-09	0.4	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783277~206783297:+
BLCA	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	6.04	3.77e-09	0.39	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
BLCA	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	6.04	3.77e-09	0.39	0.3	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
BLCA	cis	rs6681460	0.634	rs4142763	MIMAT0014979	hsa-miR-3117-3p	-6.03	3.85e-09	-0.38	-0.3	Presence of antiphospholipid antibodies;	chr1:66532353	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs967325	MIMAT0014979	hsa-miR-3117-3p	-6.02	4.26e-09	-0.37	-0.3	Presence of antiphospholipid antibodies;	chr1:66538039	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	6	4.68e-09	0.26	0.3	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
BLCA	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-5.98	5.07e-09	-0.35	-0.3	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-5.98	5.11e-09	-0.25	-0.3	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-5.98	5.14e-09	-0.28	-0.3	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
BLCA	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-5.98	5.29e-09	-0.34	-0.29	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs12094526	MIMAT0014979	hsa-miR-3117-3p	-5.97	5.47e-09	-0.34	-0.29	Menopause (age at onset);	chr1:66660431	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.634	rs12143964	MIMAT0014979	hsa-miR-3117-3p	-5.95	6.01e-09	-0.37	-0.29	Presence of antiphospholipid antibodies;	chr1:66544583	chr1:66628485~66628505:+
BLCA	cis	rs75358501	0.636	rs11895370	MIMAT0014994	hsa-miR-3130-3p	5.93	6.81e-09	0.39	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783245~206783265:-
BLCA	cis	rs75358501	0.636	rs11895370	MIMAT0014994_1	hsa-miR-3130-3p	5.93	6.81e-09	0.39	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783277~206783297:+
BLCA	cis	rs1867631	0.565	rs10749764	MIMAT0014979	hsa-miR-3117-3p	-5.93	7e-09	-0.34	-0.29	Menopause (age at onset);	chr1:66684023	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs6694782	MIMAT0014979	hsa-miR-3117-3p	5.92	7.23e-09	0.34	0.29	Menopause (age at onset);	chr1:66661079	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs10889625	MIMAT0014979	hsa-miR-3117-3p	-5.9	7.96e-09	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66541552	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.576	rs7354930	MIMAT0014979	hsa-miR-3117-3p	-5.9	8.3e-09	-0.37	-0.29	Presence of antiphospholipid antibodies;	chr1:66520694	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.576	rs1338194	MIMAT0014979	hsa-miR-3117-3p	-5.9	8.3e-09	-0.37	-0.29	Presence of antiphospholipid antibodies;	chr1:66520793	chr1:66628485~66628505:+
BLCA	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-5.89	8.64e-09	-0.34	-0.29	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.674	rs7543607	MIMAT0014979	hsa-miR-3117-3p	-5.88	8.91e-09	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66546909	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs1947083	MIMAT0014979	hsa-miR-3117-3p	-5.87	9.61e-09	-0.35	-0.29	Presence of antiphospholipid antibodies;	chr1:66539118	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs1856315	MIMAT0014979	hsa-miR-3117-3p	-5.87	9.61e-09	-0.35	-0.29	Presence of antiphospholipid antibodies;	chr1:66539546	chr1:66628485~66628505:+
BLCA	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-5.84	1.15e-08	-0.41	-0.29	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.674	rs2121051	MIMAT0014979	hsa-miR-3117-3p	-5.83	1.2e-08	-0.36	-0.29	Presence of antiphospholipid antibodies;	chr1:66551494	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.608	rs10889624	MIMAT0014979	hsa-miR-3117-3p	-5.83	1.21e-08	-0.35	-0.29	Presence of antiphospholipid antibodies;	chr1:66540124	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.706	rs13147491	MIMAT0003242	hsa-miR-577	5.81	1.33e-08	0.47	0.29	Hemoglobin concentration;	chr4:114696462	chr4:114656774~114656794:+
BLCA	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-5.81	1.36e-08	-0.34	-0.29	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs1338184	MIMAT0014979	hsa-miR-3117-3p	5.8	1.39e-08	0.35	0.29	Presence of antiphospholipid antibodies;	chr1:66539389	chr1:66628485~66628505:+
BLCA	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	5.79	1.48e-08	0.33	0.29	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs1415984	MIMAT0014979	hsa-miR-3117-3p	-5.78	1.54e-08	-0.37	-0.29	Presence of antiphospholipid antibodies;	chr1:66536434	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-5.77	1.66e-08	-0.34	-0.29	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-5.77	1.68e-08	-0.34	-0.29	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-5.76	1.77e-08	-0.28	-0.29	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-5.75	1.87e-08	-0.24	-0.28	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
BLCA	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-5.74	1.99e-08	-0.28	-0.28	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	5.74	2e-08	0.23	0.28	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	5.74	2e-08	0.23	0.28	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	5.74	2e-08	0.23	0.28	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-5.72	2.21e-08	-0.23	-0.28	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	5.72	2.22e-08	0.23	0.28	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
BLCA	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	5.72	2.22e-08	0.39	0.28	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
BLCA	cis	rs2069426	1	rs17756311	MIMAT0004504	hsa-miR-31-3p	-5.71	2.34e-08	-0.42	-0.28	Acute lymphoblastic leukemia (childhood);	chr9:22053896	chr9:21512121~21512142:-
BLCA	cis	rs6681460	0.866	rs996123	MIMAT0014979	hsa-miR-3117-3p	-5.7	2.38e-08	-0.34	-0.28	Presence of antiphospholipid antibodies;	chr1:66559660	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	5.7	2.4e-08	0.33	0.28	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-5.7	2.47e-08	-0.18	-0.28	Migraine;	chr10:103286250	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-5.7	2.47e-08	-0.18	-0.28	Migraine;	chr10:103286932	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-5.69	2.63e-08	-0.17	-0.28	Migraine;	chr10:103415374	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-5.68	2.74e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-5.67	2.89e-08	-0.18	-0.28	Migraine;	chr10:103295206	chr10:103394301~103394322:-
BLCA	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	5.66	2.96e-08	0.41	0.28	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.649	rs4655494	MIMAT0014979	hsa-miR-3117-3p	-5.66	2.96e-08	-0.34	-0.28	Presence of antiphospholipid antibodies;	chr1:66537193	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.649	rs967322	MIMAT0014979	hsa-miR-3117-3p	-5.66	2.96e-08	-0.34	-0.28	Presence of antiphospholipid antibodies;	chr1:66537763	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-5.66	3.01e-08	-0.17	-0.28	Migraine;	chr10:103254113	chr10:103394301~103394322:-
BLCA	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-5.65	3.14e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
BLCA	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	5.64	3.3e-08	0.17	0.28	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.866	rs1856318	MIMAT0014979	hsa-miR-3117-3p	-5.64	3.34e-08	-0.34	-0.28	Presence of antiphospholipid antibodies;	chr1:66558532	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-5.64	3.4e-08	-0.18	-0.28	Migraine;	chr10:103296155	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.649	rs1415974	MIMAT0014979	hsa-miR-3117-3p	5.64	3.41e-08	0.34	0.28	Presence of antiphospholipid antibodies;	chr1:66539820	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-5.64	3.41e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-5.63	3.53e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-5.62	3.69e-08	-0.26	-0.28	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	5.62	3.79e-08	0.22	0.28	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	5.61	3.86e-08	0.22	0.28	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	5.61	3.86e-08	0.22	0.28	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	5.61	3.86e-08	0.22	0.28	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	5.61	3.86e-08	0.22	0.28	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	5.61	3.86e-08	0.22	0.28	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-5.61	3.89e-08	-0.17	-0.28	Migraine;	chr10:103365694	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-5.61	3.89e-08	-0.17	-0.28	Migraine;	chr10:103369141	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-5.61	3.93e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
BLCA	cis	rs1867631	0.585	rs11208940	MIMAT0014979	hsa-miR-3117-3p	5.61	3.96e-08	0.31	0.28	Menopause (age at onset);	chr1:66661559	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	5.61	4.01e-08	0.39	0.28	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs10789214	MIMAT0014979	hsa-miR-3117-3p	-5.6	4.05e-08	-0.33	-0.28	Presence of antiphospholipid antibodies;	chr1:66681134	chr1:66628485~66628505:+
BLCA	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	5.6	4.06e-08	0.22	0.28	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	5.6	4.06e-08	0.22	0.28	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	5.6	4.06e-08	0.22	0.28	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	5.6	4.06e-08	0.22	0.28	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	5.6	4.06e-08	0.22	0.28	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
BLCA	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	5.59	4.27e-08	0.39	0.28	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
BLCA	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-5.59	4.43e-08	-0.33	-0.28	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
BLCA	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-5.59	4.43e-08	-0.33	-0.28	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
BLCA	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	5.59	4.45e-08	0.39	0.28	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
BLCA	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-5.57	4.78e-08	-0.32	-0.28	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	5.57	4.84e-08	0.39	0.28	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
BLCA	cis	rs6681460	1	rs1562217	MIMAT0014979	hsa-miR-3117-3p	5.57	4.9e-08	0.32	0.28	Presence of antiphospholipid antibodies;	chr1:66607883	chr1:66628485~66628505:+
BLCA	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-5.55	5.38e-08	-0.33	-0.28	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
BLCA	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	5.55	5.54e-08	0.38	0.28	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
BLCA	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	5.55	5.54e-08	0.38	0.28	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
BLCA	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-5.53	5.94e-08	-0.33	-0.27	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs10889634	MIMAT0014979	hsa-miR-3117-3p	5.53	5.97e-08	0.32	0.27	Presence of antiphospholipid antibodies;	chr1:66600228	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-5.53	6.03e-08	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.901	rs1373911	MIMAT0014979	hsa-miR-3117-3p	-5.51	6.59e-08	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66575382	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-5.51	6.69e-08	-0.17	-0.27	Migraine;	chr10:103394332	chr10:103394301~103394322:-
BLCA	cis	rs6681460	1	rs4655648	MIMAT0014979	hsa-miR-3117-3p	-5.51	6.72e-08	-0.33	-0.27	Presence of antiphospholipid antibodies;	chr1:66648626	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-5.5	7.02e-08	-0.17	-0.27	Migraine;	chr10:103315955	chr10:103394301~103394322:-
BLCA	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	5.5	7.18e-08	0.38	0.27	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
BLCA	cis	rs6681460	1	rs10889641	MIMAT0014979	hsa-miR-3117-3p	-5.49	7.26e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66672684	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-5.49	7.32e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-5.49	7.37e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
BLCA	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	5.49	7.44e-08	0.38	0.27	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-5.49	7.5e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
BLCA	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	5.48	7.76e-08	0.22	0.27	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
BLCA	cis	rs6681460	1	rs1329978	MIMAT0014979	hsa-miR-3117-3p	-5.48	7.82e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66650548	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs10789210	MIMAT0014979	hsa-miR-3117-3p	-5.48	7.88e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66600347	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-5.48	7.93e-08	-0.4	-0.27	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.706	rs35759252	MIMAT0003242	hsa-miR-577	5.48	8.02e-08	0.45	0.27	Hemoglobin concentration;	chr4:114608520	chr4:114656774~114656794:+
BLCA	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	5.47	8.1e-08	0.38	0.27	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
BLCA	cis	rs6681460	1	rs2147777	MIMAT0014979	hsa-miR-3117-3p	-5.47	8.11e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66663571	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs6680876	MIMAT0014979	hsa-miR-3117-3p	-5.47	8.11e-08	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66663799	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	5.47	8.12e-08	0.32	0.27	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
BLCA	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-5.47	8.3e-08	-0.47	-0.27	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
BLCA	cis	rs4851551	1	rs3917329	MIMAT0019926	hsa-miR-4772-5p	-5.46	8.62e-08	-0.46	-0.27	Blood protein levels;	chr2:102179403	chr2:102432300~102432321:+
BLCA	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-5.45	9.2e-08	-0.32	-0.27	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.706	rs13134858	MIMAT0003242	hsa-miR-577	5.44	9.41e-08	0.45	0.27	Hemoglobin concentration;	chr4:114601150	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.706	rs35571359	MIMAT0003242	hsa-miR-577	5.44	9.41e-08	0.45	0.27	Hemoglobin concentration;	chr4:114606130	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	5.43	9.9e-08	0.38	0.27	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
BLCA	cis	rs4851551	1	rs4851552	MIMAT0019926	hsa-miR-4772-5p	5.43	1.01e-07	0.47	0.27	Blood protein levels;	chr2:102185873	chr2:102432300~102432321:+
BLCA	cis	rs4851551	1	rs4851551	MIMAT0019926	hsa-miR-4772-5p	5.43	1.04e-07	0.47	0.27	Blood protein levels;	chr2:102183770	chr2:102432300~102432321:+
BLCA	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	5.42	1.08e-07	0.31	0.27	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-5.41	1.1e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
BLCA	cis	rs62560775	0.688	rs3217986	MIMAT0004504	hsa-miR-31-3p	5.41	1.11e-07	0.42	0.27	Lung cancer;Lung adenocarcinoma;	chr9:22005331	chr9:21512121~21512142:-
BLCA	cis	rs6681460	1	rs4655636	MIMAT0014979	hsa-miR-3117-3p	-5.41	1.15e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66602854	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs7524818	MIMAT0014979	hsa-miR-3117-3p	-5.41	1.15e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66606348	chr1:66628485~66628505:+
BLCA	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-5.4	1.17e-07	-0.47	-0.27	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
BLCA	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	5.4	1.18e-07	0.38	0.27	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
BLCA	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	5.4	1.18e-07	0.17	0.27	Migraine;	chr10:103236031	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-5.4	1.18e-07	-0.17	-0.27	Migraine;	chr10:103338267	chr10:103394301~103394322:-
BLCA	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	5.4	1.19e-07	0.37	0.27	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.649	rs7540195	MIMAT0014979	hsa-miR-3117-3p	5.39	1.26e-07	0.34	0.27	Presence of antiphospholipid antibodies;	chr1:66536723	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-5.39	1.28e-07	-0.32	-0.27	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs6588207	MIMAT0014979	hsa-miR-3117-3p	-5.38	1.33e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66600872	chr1:66628485~66628505:+
BLCA	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-5.37	1.38e-07	-0.32	-0.27	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-5.37	1.39e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
BLCA	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-5.37	1.42e-07	-0.23	-0.27	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
BLCA	cis	rs6681460	1	rs6689864	MIMAT0014979	hsa-miR-3117-3p	-5.36	1.42e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66602429	chr1:66628485~66628505:+
BLCA	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	5.36	1.42e-07	0.37	0.27	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	5.36	1.47e-07	0.39	0.27	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	5.36	1.47e-07	0.39	0.27	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
BLCA	cis	rs6681460	1	rs6697088	MIMAT0014979	hsa-miR-3117-3p	5.36	1.49e-07	0.31	0.27	Presence of antiphospholipid antibodies;	chr1:66579041	chr1:66628485~66628505:+
BLCA	cis	rs7022762	1	rs7022762	MIMAT0000090	hsa-miR-32-5p	-5.35	1.5e-07	-0.42	-0.27	Peripheral arterial disease (traffic-related air pollution interaction);	chr9:108091224	chr9:109046272~109046293:-
BLCA	cis	rs6681460	0.934	rs4655631	MIMAT0014979	hsa-miR-3117-3p	-5.35	1.51e-07	-0.31	-0.27	Presence of antiphospholipid antibodies;	chr1:66589224	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	5.34	1.59e-07	0.4	0.27	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	5.34	1.6e-07	0.37	0.27	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
BLCA	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	5.34	1.62e-07	0.18	0.27	Migraine;	chr10:103263177	chr10:103394341~103394361:-
BLCA	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	5.34	1.62e-07	0.21	0.27	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
BLCA	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	5.34	1.62e-07	0.21	0.27	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
BLCA	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	5.33	1.67e-07	0.39	0.27	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
BLCA	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	5.33	1.68e-07	0.37	0.27	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
BLCA	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-5.33	1.71e-07	-0.46	-0.27	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
BLCA	cis	rs6681460	1	rs2872078	MIMAT0014979	hsa-miR-3117-3p	-5.32	1.81e-07	-0.32	-0.26	Presence of antiphospholipid antibodies;	chr1:66661684	chr1:66628485~66628505:+
BLCA	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	5.31	1.87e-07	0.37	0.26	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	5.31	1.88e-07	0.39	0.26	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
BLCA	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	5.31	1.89e-07	0.21	0.26	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
BLCA	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-5.3	1.93e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-5.3	1.93e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-5.3	1.97e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
BLCA	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	5.3	1.98e-07	0.36	0.26	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	5.3	2.02e-07	0.39	0.26	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	5.29	2.06e-07	0.39	0.26	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
BLCA	cis	rs2069426	1	rs17756311	MIMAT0000089	hsa-miR-31-5p	-5.29	2.08e-07	-0.39	-0.26	Acute lymphoblastic leukemia (childhood);	chr9:22053896	chr9:21512158~21512178:-
BLCA	cis	rs6681460	1	rs9662962	MIMAT0014979	hsa-miR-3117-3p	-5.29	2.1e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66655681	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs9659879	MIMAT0014979	hsa-miR-3117-3p	-5.29	2.1e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66655751	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-5.29	2.1e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-5.29	2.1e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-5.29	2.1e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	5.28	2.18e-07	0.39	0.26	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	5.27	2.26e-07	0.4	0.26	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	5.27	2.26e-07	0.4	0.26	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	5.27	2.26e-07	0.4	0.26	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	5.27	2.26e-07	0.4	0.26	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	5.27	2.26e-07	0.4	0.26	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	5.27	2.26e-07	0.4	0.26	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
BLCA	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-5.27	2.28e-07	-0.46	-0.26	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
BLCA	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	5.27	2.3e-07	0.37	0.26	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-5.26	2.37e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-5.26	2.48e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-5.26	2.48e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	5.25	2.5e-07	0.39	0.26	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	5.25	2.5e-07	0.39	0.26	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
BLCA	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	5.24	2.68e-07	0.37	0.26	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
BLCA	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	5.24	2.68e-07	0.37	0.26	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-5.23	2.82e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-5.23	2.87e-07	-0.39	-0.26	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs10749763	MIMAT0014979	hsa-miR-3117-3p	-5.21	3.11e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66596443	chr1:66628485~66628505:+
BLCA	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-5.21	3.19e-07	-0.41	-0.26	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
BLCA	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	5.2	3.33e-07	0.39	0.26	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs4655650	MIMAT0014979	hsa-miR-3117-3p	-5.17	3.76e-07	-0.3	-0.26	Presence of antiphospholipid antibodies;	chr1:66676603	chr1:66628485~66628505:+
BLCA	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	5.17	3.84e-07	0.44	0.26	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
BLCA	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	5.17	3.86e-07	0.36	0.26	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	5.17	3.88e-07	0.38	0.26	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
BLCA	cis	rs6681460	1	rs1536115	MIMAT0014979	hsa-miR-3117-3p	-5.16	4.07e-07	-0.31	-0.26	Presence of antiphospholipid antibodies;	chr1:66655318	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs7532173	MIMAT0014979	hsa-miR-3117-3p	-5.15	4.22e-07	-0.3	-0.26	Presence of antiphospholipid antibodies;	chr1:66620428	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.834	rs2916	MIMAT0014979	hsa-miR-3117-3p	5.13	4.58e-07	0.31	0.26	Presence of antiphospholipid antibodies;	chr1:66751014	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.834	rs1280310	MIMAT0014979	hsa-miR-3117-3p	5.13	4.58e-07	0.31	0.26	Presence of antiphospholipid antibodies;	chr1:66751140	chr1:66628485~66628505:+
BLCA	cis	rs1163656	0.536	rs7306751	MIMAT0003287	hsa-miR-618	-5.13	4.65e-07	-0.41	-0.26	Dental caries;	chr12:80922459	chr12:80935796~80935818:-
BLCA	cis	rs4851551	0.867	rs2228139	MIMAT0019926	hsa-miR-4772-5p	5.1	5.48e-07	0.44	0.25	Blood protein levels;	chr2:102165189	chr2:102432300~102432321:+
BLCA	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-5.08	5.82e-07	-0.17	-0.25	Migraine;	chr10:103365694	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-5.08	5.82e-07	-0.17	-0.25	Migraine;	chr10:103369141	chr10:103394341~103394361:-
BLCA	cis	rs6681460	0.932	rs2044399	MIMAT0014979	hsa-miR-3117-3p	-5.08	5.83e-07	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66588397	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs2044400	MIMAT0014979	hsa-miR-3117-3p	-5.08	5.83e-07	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66588398	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-5.08	5.98e-07	-0.17	-0.25	Migraine;	chr10:103254113	chr10:103394341~103394361:-
BLCA	cis	rs6681460	0.966	rs7542924	MIMAT0014979	hsa-miR-3117-3p	-5.07	6.22e-07	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66677372	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs523188	MIMAT0014979	hsa-miR-3117-3p	-5.07	6.28e-07	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66708739	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs6656912	MIMAT0014979	hsa-miR-3117-3p	-5.07	6.34e-07	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66617988	chr1:66628485~66628505:+
BLCA	cis	rs4851551	0.867	rs3917299	MIMAT0019926	hsa-miR-4772-5p	5.07	6.37e-07	0.43	0.25	Blood protein levels;	chr2:102169626	chr2:102432300~102432321:+
BLCA	cis	rs2069426	1	rs80166549	MIMAT0004504	hsa-miR-31-3p	-5.06	6.53e-07	-0.47	-0.25	Acute lymphoblastic leukemia (childhood);	chr9:22041156	chr9:21512121~21512142:-
BLCA	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	5.05	6.77e-07	0.17	0.25	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
BLCA	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	5.03	7.73e-07	0.37	0.25	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	5.03	7.73e-07	0.37	0.25	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.934	rs4655635	MIMAT0014979	hsa-miR-3117-3p	-5.02	7.87e-07	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66602557	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs9662943	MIMAT0014979	hsa-miR-3117-3p	5.02	8.11e-07	0.3	0.25	Presence of antiphospholipid antibodies;	chr1:66655449	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-5.01	8.46e-07	-0.17	-0.25	Migraine;	chr10:103415374	chr10:103394341~103394361:-
BLCA	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	5.01	8.6e-07	0.35	0.25	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	5.01	8.6e-07	0.35	0.25	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.932	rs602513	MIMAT0014979	hsa-miR-3117-3p	-5	8.72e-07	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66711587	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	5	8.96e-07	0.33	0.25	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	4.99	9.05e-07	0.3	0.25	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	4.98	9.81e-07	0.36	0.25	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	4.98	9.93e-07	0.36	0.25	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	4.97	1.04e-06	0.36	0.25	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.966	rs4655506	MIMAT0014979	hsa-miR-3117-3p	-4.95	1.11e-06	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66685128	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.8	rs539014	MIMAT0014979	hsa-miR-3117-3p	4.95	1.11e-06	0.29	0.25	Presence of antiphospholipid antibodies;	chr1:66746204	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.12e-06	-0.17	-0.25	Migraine;	chr10:103295206	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.13e-06	-0.17	-0.25	Migraine;	chr10:103286250	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-4.95	1.13e-06	-0.17	-0.25	Migraine;	chr10:103286932	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-4.94	1.16e-06	-0.14	-0.25	Migraine;	chr10:103284400	chr10:103394301~103394322:-
BLCA	cis	rs2069426	1	rs80166549	MIMAT0000089	hsa-miR-31-5p	-4.94	1.19e-06	-0.45	-0.25	Acute lymphoblastic leukemia (childhood);	chr9:22041156	chr9:21512158~21512178:-
BLCA	cis	rs2069426	0.722	rs598664	MIMAT0004504	hsa-miR-31-3p	4.92	1.29e-06	0.48	0.25	Acute lymphoblastic leukemia (childhood);	chr9:22027552	chr9:21512121~21512142:-
BLCA	cis	rs6681460	0.899	rs502690	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.3e-06	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66716720	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs536410	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.32e-06	-0.3	-0.25	Presence of antiphospholipid antibodies;	chr1:66725401	chr1:66628485~66628505:+
BLCA	cis	rs6681460	1	rs1445575	MIMAT0014979	hsa-miR-3117-3p	-4.9	1.43e-06	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66586481	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.934	rs4655628	MIMAT0014979	hsa-miR-3117-3p	-4.9	1.43e-06	-0.29	-0.25	Presence of antiphospholipid antibodies;	chr1:66586926	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-4.89	1.46e-06	-0.17	-0.25	Migraine;	chr10:103394332	chr10:103394341~103394361:-
BLCA	cis	rs6681460	0.671	rs628655	MIMAT0014979	hsa-miR-3117-3p	4.88	1.54e-06	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66747890	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-4.88	1.55e-06	-0.17	-0.24	Migraine;	chr10:103296155	chr10:103394341~103394361:-
BLCA	cis	rs4851551	0.867	rs3917289	MIMAT0019926	hsa-miR-4772-5p	4.88	1.6e-06	0.4	0.24	Blood protein levels;	chr2:102165451	chr2:102432300~102432321:+
BLCA	cis	rs6681460	1	rs964574	MIMAT0014979	hsa-miR-3117-3p	-4.88	1.6e-06	-0.29	-0.24	Presence of antiphospholipid antibodies;	chr1:66597202	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs523132	MIMAT0014979	hsa-miR-3117-3p	4.86	1.7e-06	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66708757	chr1:66628485~66628505:+
BLCA	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	4.86	1.7e-06	0.33	0.24	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	4.86	1.74e-06	0.36	0.24	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
BLCA	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-4.86	1.75e-06	-0.31	-0.24	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
BLCA	cis	rs1712517	0.838	rs6584543	MIMAT0005951	hsa-miR-1307-3p	4.83	1.95e-06	0.14	0.24	Migraine;	chr10:103237257	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-4.82	2.06e-06	-0.17	-0.24	Migraine;	chr10:103315955	chr10:103394341~103394361:-
BLCA	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-4.82	2.11e-06	-0.29	-0.24	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-4.8	2.26e-06	-0.17	-0.24	Migraine;	chr10:103338267	chr10:103394341~103394361:-
BLCA	cis	rs4851551	0.867	rs3917330	MIMAT0019926	hsa-miR-4772-5p	4.8	2.33e-06	0.4	0.24	Blood protein levels;	chr2:102179965	chr2:102432300~102432321:+
BLCA	cis	rs4851551	0.867	rs3917331	MIMAT0019926	hsa-miR-4772-5p	4.8	2.33e-06	0.4	0.24	Blood protein levels;	chr2:102179966	chr2:102432300~102432321:+
BLCA	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-4.8	2.35e-06	-0.14	-0.24	Migraine;	chr10:103278698	chr10:103394301~103394322:-
BLCA	cis	rs6558174	0.965	rs7831119	MIMAT0000510	hsa-miR-320a-3p	-4.78	2.52e-06	-0.21	-0.24	Breast cancer;	chr8:22632165	chr8:22244975~22244996:-
BLCA	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	4.78	2.53e-06	0.33	0.24	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
BLCA	cis	rs6681460	0.834	rs544258	MIMAT0014979	hsa-miR-3117-3p	4.78	2.55e-06	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66753526	chr1:66628485~66628505:+
BLCA	cis	rs62560775	0.688	rs3217986	MIMAT0000089	hsa-miR-31-5p	4.77	2.62e-06	0.37	0.24	Lung cancer;Lung adenocarcinoma;	chr9:22005331	chr9:21512158~21512178:-
BLCA	cis	rs6681460	0.898	rs1032635	MIMAT0014979	hsa-miR-3117-3p	4.77	2.63e-06	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66729501	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-4.76	2.73e-06	-0.28	-0.24	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs659291	MIMAT0014979	hsa-miR-3117-3p	-4.76	2.74e-06	-0.29	-0.24	Presence of antiphospholipid antibodies;	chr1:66715063	chr1:66628485~66628505:+
BLCA	cis	rs2277912	0.865	rs111954117	MIMAT0014995	hsa-miR-3130-5p	4.75	2.85e-06	0.28	0.24	Height;	chr2:206793017	chr2:206783276~206783296:-
BLCA	cis	rs2277912	0.865	rs111954117	MIMAT0014995_1	hsa-miR-3130-5p	4.75	2.85e-06	0.28	0.24	Height;	chr2:206793017	chr2:206783246~206783266:+
BLCA	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-4.74	3.07e-06	-0.28	-0.24	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
BLCA	cis	rs4851551	0.867	rs3171845	MIMAT0019926	hsa-miR-4772-5p	4.74	3.09e-06	0.39	0.24	Blood protein levels;	chr2:102174921	chr2:102432300~102432321:+
BLCA	cis	rs2069426	1	rs116729641	MIMAT0004504	hsa-miR-31-3p	-4.73	3.14e-06	-0.47	-0.24	Acute lymphoblastic leukemia (childhood);	chr9:22025433	chr9:21512121~21512142:-
BLCA	cis	rs2069426	1	rs77284052	MIMAT0004504	hsa-miR-31-3p	-4.73	3.14e-06	-0.47	-0.24	Acute lymphoblastic leukemia (childhood);	chr9:22025886	chr9:21512121~21512142:-
BLCA	cis	rs6681460	0.932	rs603750	MIMAT0014979	hsa-miR-3117-3p	-4.73	3.2e-06	-0.28	-0.24	Presence of antiphospholipid antibodies;	chr1:66711805	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.966	rs2025595	MIMAT0014979	hsa-miR-3117-3p	-4.72	3.3e-06	-0.28	-0.24	Presence of antiphospholipid antibodies;	chr1:66686816	chr1:66628485~66628505:+
BLCA	cis	rs7851726	0.628	rs4744412	MIMAT0019208	hsa-miR-3074-5p	4.7	3.59e-06	0.18	0.24	Urinary albumin-to-creatinine ratio;	chr9:94928219	chr9:95086063~95086083:-
BLCA	cis	rs1712517	0.873	rs7916056	MIMAT0005951	hsa-miR-1307-3p	4.7	3.64e-06	0.14	0.24	Migraine;	chr10:103238157	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.773	rs515944	MIMAT0014979	hsa-miR-3117-3p	4.7	3.7e-06	0.29	0.24	Presence of antiphospholipid antibodies;	chr1:66754297	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	4.7	3.74e-06	0.28	0.24	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
BLCA	cis	rs75358501	0.636	rs10932164	MIMAT0014994	hsa-miR-3130-3p	4.69	3.78e-06	0.34	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783245~206783265:-
BLCA	cis	rs75358501	0.636	rs10932164	MIMAT0014994_1	hsa-miR-3130-3p	4.69	3.78e-06	0.34	0.24	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783277~206783297:+
BLCA	cis	rs1712517	0.873	rs7894240	MIMAT0005951	hsa-miR-1307-3p	4.69	3.82e-06	0.14	0.24	Migraine;	chr10:103240612	chr10:103394301~103394322:-
BLCA	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-4.68	4.06e-06	-0.18	-0.23	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
BLCA	cis	rs523340	1	rs1519466	MIMAT0000090	hsa-miR-32-5p	-4.68	4.06e-06	-0.25	-0.23	Information processing speed;	chr9:109098517	chr9:109046272~109046293:-
BLCA	cis	rs6681460	0.933	rs7554101	MIMAT0014979	hsa-miR-3117-3p	4.67	4.27e-06	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66690789	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.932	rs665319	MIMAT0014979	hsa-miR-3117-3p	-4.67	4.28e-06	-0.28	-0.23	Presence of antiphospholipid antibodies;	chr1:66709805	chr1:66628485~66628505:+
BLCA	cis	rs2069426	1	rs17694572	MIMAT0004504	hsa-miR-31-3p	-4.65	4.55e-06	-0.4	-0.23	Acute lymphoblastic leukemia (childhood);	chr9:22054357	chr9:21512121~21512142:-
BLCA	cis	rs2069426	0.722	rs598664	MIMAT0000089	hsa-miR-31-5p	4.65	4.56e-06	0.45	0.23	Acute lymphoblastic leukemia (childhood);	chr9:22027552	chr9:21512158~21512178:-
BLCA	cis	rs6681460	0.932	rs2483705	MIMAT0014979	hsa-miR-3117-3p	4.62	5.28e-06	0.28	0.23	Presence of antiphospholipid antibodies;	chr1:66725497	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-4.61	5.51e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-4.61	5.55e-06	-0.13	-0.23	Migraine;	chr10:103270083	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-4.61	5.65e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-4.61	5.65e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
BLCA	cis	rs950880	0.71	rs17027166	MIMAT0019927	hsa-miR-4772-3p	4.6	5.75e-06	0.23	0.23	Serum protein levels (sST2);	chr2:102438960	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.873	rs7903004	MIMAT0005951	hsa-miR-1307-3p	4.59	5.98e-06	0.14	0.23	Migraine;	chr10:103244344	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-4.59	6.01e-06	-0.14	-0.23	Migraine;	chr10:103273871	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-4.59	6.1e-06	-0.13	-0.23	Migraine;	chr10:103262005	chr10:103394301~103394322:-
BLCA	cis	rs1558648	0.858	rs12996377	MIMAT0019927	hsa-miR-4772-3p	-4.58	6.29e-06	-0.26	-0.23	Serum protein levels (sST2);	chr2:102214018	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.932	rs492109	MIMAT0014979	hsa-miR-3117-3p	4.57	6.59e-06	0.27	0.23	Presence of antiphospholipid antibodies;	chr1:66721450	chr1:66628485~66628505:+
BLCA	cis	rs7851726	0.628	rs12344211	MIMAT0019208	hsa-miR-3074-5p	4.57	6.61e-06	0.18	0.23	Urinary albumin-to-creatinine ratio;	chr9:94928822	chr9:95086063~95086083:-
BLCA	cis	rs1018697	1	rs7080587	MIMAT0005951	hsa-miR-1307-3p	4.57	6.72e-06	0.13	0.23	Colorectal adenoma (advanced);	chr10:102785517	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	4.56	6.79e-06	0.15	0.23	Migraine;	chr10:103241753	chr10:103394341~103394361:-
BLCA	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-4.56	7.01e-06	-0.27	-0.23	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-4.55	7.21e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.8	rs481681	MIMAT0014979	hsa-miR-3117-3p	4.55	7.31e-06	0.27	0.23	Presence of antiphospholipid antibodies;	chr1:66728695	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-4.54	7.48e-06	-0.14	-0.23	Migraine;	chr10:103283532	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-4.54	7.48e-06	-0.14	-0.23	Migraine;	chr10:103284207	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.835	rs2506961	MIMAT0005951	hsa-miR-1307-3p	4.54	7.52e-06	0.13	0.23	Migraine;	chr10:103248169	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.873	rs1712510	MIMAT0005951	hsa-miR-1307-3p	4.54	7.52e-06	0.13	0.23	Migraine;	chr10:103249329	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.898	rs1032634	MIMAT0014979	hsa-miR-3117-3p	4.54	7.55e-06	0.27	0.23	Presence of antiphospholipid antibodies;	chr1:66729509	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-4.54	7.66e-06	-0.13	-0.23	Migraine;	chr10:103279822	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-4.52	8.26e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	4.52	8.38e-06	0.15	0.23	Migraine;	chr10:103236031	chr10:103394341~103394361:-
BLCA	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	4.51	8.53e-06	0.27	0.23	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
BLCA	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	4.5	8.96e-06	0.25	0.23	Asthma;	chr2:102344364	chr2:102432300~102432321:+
BLCA	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-4.49	9.68e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
BLCA	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	4.48	9.84e-06	0.18	0.23	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	4.48	9.84e-06	0.18	0.23	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
BLCA	cis	rs4851551	0.543	rs11887842	MIMAT0019927	hsa-miR-4772-3p	-4.48	9.98e-06	-0.3	-0.23	Blood protein levels;	chr2:102223018	chr2:102432336~102432357:+
BLCA	cis	rs4851551	0.543	rs17026757	MIMAT0019927	hsa-miR-4772-3p	-4.48	9.98e-06	-0.3	-0.23	Blood protein levels;	chr2:102197452	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	4.47	1.03e-05	0.13	0.23	Migraine;	chr10:103261506	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	4.47	1.03e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.8	rs485543	MIMAT0014979	hsa-miR-3117-3p	4.47	1.04e-05	0.27	0.22	Presence of antiphospholipid antibodies;	chr1:66728689	chr1:66628485~66628505:+
BLCA	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	4.47	1.04e-05	0.23	0.22	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
BLCA	cis	rs2069426	1	rs116729641	MIMAT0000089	hsa-miR-31-5p	-4.47	1.05e-05	-0.43	-0.22	Acute lymphoblastic leukemia (childhood);	chr9:22025433	chr9:21512158~21512178:-
BLCA	cis	rs2069426	1	rs77284052	MIMAT0000089	hsa-miR-31-5p	-4.47	1.05e-05	-0.43	-0.22	Acute lymphoblastic leukemia (childhood);	chr9:22025886	chr9:21512158~21512178:-
BLCA	cis	rs6681460	0.898	rs536527	MIMAT0014979	hsa-miR-3117-3p	-4.46	1.09e-05	-0.27	-0.22	Presence of antiphospholipid antibodies;	chr1:66728110	chr1:66628485~66628505:+
BLCA	cis	rs2069426	1	rs17694572	MIMAT0000089	hsa-miR-31-5p	-4.46	1.09e-05	-0.38	-0.22	Acute lymphoblastic leukemia (childhood);	chr9:22054357	chr9:21512158~21512178:-
BLCA	cis	rs4851551	0.543	rs1997503	MIMAT0019927	hsa-miR-4772-3p	-4.46	1.09e-05	-0.29	-0.22	Blood protein levels;	chr2:102192775	chr2:102432336~102432357:+
BLCA	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	4.45	1.12e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	4.45	1.12e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	4.45	1.12e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	4.44	1.17e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
BLCA	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-4.44	1.18e-05	-0.25	-0.22	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
BLCA	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-4.44	1.21e-05	-0.25	-0.22	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
BLCA	cis	rs4851551	0.543	rs62156407	MIMAT0019926	hsa-miR-4772-5p	4.43	1.23e-05	0.4	0.22	Blood protein levels;	chr2:102208162	chr2:102432300~102432321:+
BLCA	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	4.43	1.26e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	4.43	1.26e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	4.43	1.26e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	4.43	1.26e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
BLCA	cis	rs6558174	0.965	rs4872524	MIMAT0000510	hsa-miR-320a-3p	4.43	1.26e-05	0.2	0.22	Breast cancer;	chr8:22632024	chr8:22244975~22244996:-
BLCA	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	4.42	1.27e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
BLCA	cis	rs1558648	0.858	rs13014004	MIMAT0019927	hsa-miR-4772-3p	-4.41	1.32e-05	-0.25	-0.22	Serum protein levels (sST2);	chr2:102224207	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	4.41	1.34e-05	0.24	0.22	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
BLCA	cis	rs1712517	0.873	rs1891292	MIMAT0005951	hsa-miR-1307-3p	4.41	1.34e-05	0.13	0.22	Migraine;	chr10:103241753	chr10:103394301~103394322:-
BLCA	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	4.4	1.4e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs10147934	MIMAT0022287	hsa-miR-5586-5p	-4.4	1.44e-05	-0.2	-0.22	Schizophrenia;	chr14:59743864	chr14:59646999~59647020:-
BLCA	cis	rs6681460	0.898	rs2483704	MIMAT0014979	hsa-miR-3117-3p	4.4	1.44e-05	0.26	0.22	Presence of antiphospholipid antibodies;	chr1:66729670	chr1:66628485~66628505:+
BLCA	cis	rs12431410	0.55	rs10150849	MIMAT0022287	hsa-miR-5586-5p	-4.39	1.45e-05	-0.2	-0.22	Schizophrenia;	chr14:59744726	chr14:59646999~59647020:-
BLCA	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-4.39	1.47e-05	-0.26	-0.22	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
BLCA	cis	rs1558648	1	rs1558648	MIMAT0019927	hsa-miR-4772-3p	-4.39	1.48e-05	-0.26	-0.22	Serum protein levels (sST2);	chr2:102193708	chr2:102432336~102432357:+
BLCA	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-4.38	1.51e-05	-0.13	-0.22	Migraine;	chr10:103273985	chr10:103394301~103394322:-
BLCA	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-4.38	1.53e-05	-0.13	-0.22	Migraine;	chr10:103279291	chr10:103394301~103394322:-
BLCA	cis	rs7210990	0.699	rs4792721	MIMAT0005942	hsa-miR-1288-3p	-4.37	1.63e-05	-0.22	-0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16103513	chr17:16282058~16282078:+
BLCA	cis	rs7917772	0.715	rs7077678	MIMAT0005951	hsa-miR-1307-3p	-4.37	1.64e-05	-0.13	-0.22	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102678808	chr10:103394301~103394322:-
BLCA	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	4.37	1.65e-05	0.2	0.22	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
BLCA	cis	rs950880	0.71	rs11123929	MIMAT0019927	hsa-miR-4772-3p	4.36	1.66e-05	0.2	0.22	Serum protein levels (sST2);	chr2:102450683	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-4.36	1.68e-05	-0.24	-0.22	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
BLCA	cis	rs950880	0.71	rs55742125	MIMAT0019927	hsa-miR-4772-3p	4.36	1.68e-05	0.2	0.22	Serum protein levels (sST2);	chr2:102403322	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	4.36	1.68e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
BLCA	cis	rs6681460	0.932	rs524114	MIMAT0014979	hsa-miR-3117-3p	4.36	1.69e-05	0.26	0.22	Presence of antiphospholipid antibodies;	chr1:66722652	chr1:66628485~66628505:+
BLCA	cis	rs12431410	0.55	rs11847286	MIMAT0022287	hsa-miR-5586-5p	4.35	1.74e-05	0.2	0.22	Schizophrenia;	chr14:59742345	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	4.35	1.75e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	4.35	1.76e-05	0.18	0.22	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs12894486	MIMAT0022287	hsa-miR-5586-5p	-4.34	1.8e-05	-0.2	-0.22	Schizophrenia;	chr14:59756347	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.584	rs12882475	MIMAT0022287	hsa-miR-5586-5p	-4.34	1.8e-05	-0.2	-0.22	Schizophrenia;	chr14:59761337	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs7150949	MIMAT0022287	hsa-miR-5586-5p	-4.34	1.8e-05	-0.2	-0.22	Schizophrenia;	chr14:59762242	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs10135659	MIMAT0022287	hsa-miR-5586-5p	-4.34	1.8e-05	-0.2	-0.22	Schizophrenia;	chr14:59762979	chr14:59646999~59647020:-
BLCA	cis	rs6681460	0.866	rs485521	MIMAT0014979	hsa-miR-3117-3p	4.34	1.8e-05	0.26	0.22	Presence of antiphospholipid antibodies;	chr1:66743879	chr1:66628485~66628505:+
BLCA	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	4.34	1.83e-05	0.13	0.22	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
BLCA	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	4.34	1.83e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
BLCA	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-4.33	1.89e-05	-0.13	-0.22	Migraine;	chr10:103273258	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs8009507	MIMAT0022287	hsa-miR-5586-5p	-4.33	1.89e-05	-0.19	-0.22	Schizophrenia;	chr14:59764102	chr14:59646999~59647020:-
BLCA	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	4.33	1.91e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.873	rs7913461	MIMAT0005951	hsa-miR-1307-3p	-4.33	1.92e-05	-0.13	-0.22	Migraine;	chr10:103241568	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs55787031	MIMAT0022287	hsa-miR-5586-5p	-4.33	1.94e-05	-0.19	-0.22	Schizophrenia;	chr14:59744988	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs11847592	MIMAT0022287	hsa-miR-5586-5p	4.32	2e-05	0.2	0.22	Schizophrenia;	chr14:59743160	chr14:59646999~59647020:-
BLCA	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	4.32	2.02e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	4.32	2.02e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs12588565	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59748377	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs34338270	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59748580	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs2147831	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59751625	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.584	rs8018516	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59756259	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs1957997	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59757829	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs11158269	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59758693	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs11623385	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59759580	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs11628085	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59759652	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs8007076	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.03e-05	-0.19	-0.22	Schizophrenia;	chr14:59761690	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.516	rs12888478	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.04e-05	-0.2	-0.22	Schizophrenia;	chr14:59741590	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.584	rs7152594	MIMAT0022287	hsa-miR-5586-5p	-4.32	2.04e-05	-0.19	-0.22	Schizophrenia;	chr14:59773607	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	4.32	2.04e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.584	rs10145080	MIMAT0022287	hsa-miR-5586-5p	-4.31	2.06e-05	-0.19	-0.22	Schizophrenia;	chr14:59767384	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-4.31	2.08e-05	-0.13	-0.22	Migraine;	chr10:103297804	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-4.31	2.08e-05	-0.13	-0.22	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs11623439	MIMAT0022287	hsa-miR-5586-5p	-4.31	2.09e-05	-0.2	-0.22	Schizophrenia;	chr14:59759575	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs12896125	MIMAT0022287	hsa-miR-5586-5p	-4.31	2.09e-05	-0.2	-0.22	Schizophrenia;	chr14:59735698	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs6573283	MIMAT0022287	hsa-miR-5586-5p	-4.31	2.1e-05	-0.19	-0.22	Schizophrenia;	chr14:59762130	chr14:59646999~59647020:-
BLCA	cis	rs7851726	0.628	rs12338409	MIMAT0019208	hsa-miR-3074-5p	4.31	2.12e-05	0.17	0.22	Urinary albumin-to-creatinine ratio;	chr9:94928807	chr9:95086063~95086083:-
BLCA	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	4.3	2.14e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	4.3	2.15e-05	0.14	0.22	Migraine;	chr10:103248169	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	4.3	2.15e-05	0.14	0.22	Migraine;	chr10:103249329	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	4.3	2.21e-05	0.14	0.22	Migraine;	chr10:103240612	chr10:103394341~103394361:-
BLCA	cis	rs12431410	0.514	rs7144616	MIMAT0022287	hsa-miR-5586-5p	-4.29	2.27e-05	-0.19	-0.22	Schizophrenia;	chr14:59754731	chr14:59646999~59647020:-
BLCA	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	4.29	2.27e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.521	rs11848115	MIMAT0022287	hsa-miR-5586-5p	-4.29	2.27e-05	-0.19	-0.22	Schizophrenia;	chr14:59748273	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.584	rs34006462	MIMAT0022287	hsa-miR-5586-5p	-4.29	2.27e-05	-0.19	-0.22	Schizophrenia;	chr14:59769853	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs10145018	MIMAT0022287	hsa-miR-5586-5p	-4.28	2.33e-05	-0.19	-0.22	Schizophrenia;	chr14:59767556	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	4.28	2.35e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	4.28	2.35e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	4.28	2.36e-05	0.17	0.22	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
BLCA	cis	rs1018697	0.966	rs10748832	MIMAT0005951	hsa-miR-1307-3p	4.28	2.37e-05	0.13	0.22	Colorectal adenoma (advanced);	chr10:102808723	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.584	rs2350012	MIMAT0022287	hsa-miR-5586-5p	-4.28	2.37e-05	-0.19	-0.22	Schizophrenia;	chr14:59756035	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.584	rs2350013	MIMAT0022287	hsa-miR-5586-5p	-4.28	2.37e-05	-0.19	-0.22	Schizophrenia;	chr14:59756063	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.536	rs10148598	MIMAT0022287	hsa-miR-5586-5p	4.28	2.41e-05	0.21	0.22	Schizophrenia;	chr14:59680941	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.71	rs3732123	MIMAT0019927	hsa-miR-4772-3p	4.27	2.46e-05	0.2	0.22	Serum protein levels (sST2);	chr2:102401617	chr2:102432336~102432357:+
BLCA	cis	rs2069426	0.591	rs17694493	MIMAT0004504	hsa-miR-31-3p	4.27	2.47e-05	0.32	0.22	Acute lymphoblastic leukemia (childhood);	chr9:22041999	chr9:21512121~21512142:-
BLCA	cis	rs12431410	0.55	rs11848764	MIMAT0022287	hsa-miR-5586-5p	-4.27	2.51e-05	-0.19	-0.22	Schizophrenia;	chr14:59758084	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	4.27	2.51e-05	0.14	0.22	Migraine;	chr10:103237257	chr10:103394341~103394361:-
BLCA	cis	rs950880	0.614	rs60038017	MIMAT0019927	hsa-miR-4772-3p	4.26	2.53e-05	0.19	0.22	Serum protein levels (sST2);	chr2:102459541	chr2:102432336~102432357:+
BLCA	cis	rs6558174	0.93	rs1038311	MIMAT0000510	hsa-miR-320a-3p	4.26	2.57e-05	0.19	0.21	Breast cancer;	chr8:22631734	chr8:22244975~22244996:-
BLCA	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	4.26	2.57e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.584	rs8015726	MIMAT0022287	hsa-miR-5586-5p	4.26	2.59e-05	0.19	0.21	Schizophrenia;	chr14:59780566	chr14:59646999~59647020:-
BLCA	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-4.26	2.59e-05	-0.24	-0.21	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
BLCA	cis	rs12431410	0.55	rs2350137	MIMAT0022287	hsa-miR-5586-5p	4.26	2.6e-05	0.19	0.21	Schizophrenia;	chr14:59730551	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	4.25	2.65e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
BLCA	cis	rs32576	0.74	rs26124	MIMAT0000731	hsa-miR-378a-5p	-4.25	2.69e-05	-0.22	-0.21	Obesity-related traits;	chr5:149849085	chr5:149732829~149732850:+
BLCA	cis	rs12431410	0.584	rs11844804	MIMAT0022287	hsa-miR-5586-5p	-4.25	2.7e-05	-0.19	-0.21	Schizophrenia;	chr14:59776055	chr14:59646999~59647020:-
BLCA	cis	rs6558174	0.965	rs1564595	MIMAT0000510	hsa-miR-320a-3p	4.25	2.71e-05	0.19	0.21	Breast cancer;	chr8:22631426	chr8:22244975~22244996:-
BLCA	cis	rs12431410	0.55	rs2882301	MIMAT0022287	hsa-miR-5586-5p	-4.25	2.73e-05	-0.19	-0.21	Schizophrenia;	chr14:59769102	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	4.24	2.79e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
BLCA	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	4.24	2.85e-05	0.32	0.21	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
BLCA	cis	rs4921799	0.662	rs7465342	MIMAT0015020	hsa-miR-548v	4.23	2.95e-05	0.24	0.21	Lung cancer;Adenocarcinoma;	chr8:17679039	chr8:17681588~17681609:-
BLCA	cis	rs12431410	0.536	rs1013822	MIMAT0022287	hsa-miR-5586-5p	4.23	2.99e-05	0.21	0.21	Schizophrenia;	chr14:59683192	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	4.23	3e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	4.23	3e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	4.23	3e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.523	rs12587247	MIMAT0022287	hsa-miR-5586-5p	-4.22	3.01e-05	-0.19	-0.21	Schizophrenia;	chr14:59746657	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	4.22	3.01e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs2058659	MIMAT0019927	hsa-miR-4772-3p	4.22	3.02e-05	0.17	0.21	Asthma;	chr2:102438096	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.593	rs887971	MIMAT0019927	hsa-miR-4772-3p	4.22	3.04e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102424707	chr2:102432336~102432357:+
BLCA	cis	rs17639215	0.55	rs9679297	MIMAT0019927	hsa-miR-4772-3p	-4.22	3.06e-05	-0.19	-0.21	Serum protein levels (sST2);	chr2:102298109	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.645	rs4851006	MIMAT0019927	hsa-miR-4772-3p	4.22	3.12e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102408278	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs11693955	MIMAT0019927	hsa-miR-4772-3p	4.22	3.12e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102412705	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.744	rs3771156	MIMAT0019927	hsa-miR-4772-3p	4.22	3.12e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102420217	chr2:102432336~102432357:+
BLCA	cis	rs4851551	0.619	rs34722443	MIMAT0019926	hsa-miR-4772-5p	4.21	3.14e-05	0.39	0.21	Blood protein levels;	chr2:102223859	chr2:102432300~102432321:+
BLCA	cis	rs950880	0.71	rs17027230	MIMAT0019927	hsa-miR-4772-3p	4.21	3.19e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102462870	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs55883125	MIMAT0019927	hsa-miR-4772-3p	4.21	3.19e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102407871	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs4090473	MIMAT0019927	hsa-miR-4772-3p	4.21	3.22e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102306527	chr2:102432336~102432357:+
BLCA	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	4.2	3.28e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs1952036	MIMAT0022287	hsa-miR-5586-5p	-4.2	3.31e-05	-0.19	-0.21	Schizophrenia;	chr14:59713229	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.584	rs1952032	MIMAT0022287	hsa-miR-5586-5p	-4.2	3.32e-05	-0.19	-0.21	Schizophrenia;	chr14:59776017	chr14:59646999~59647020:-
BLCA	cis	rs250677	1	rs190378	MIMAT0022708	hsa-miR-584-3p	4.2	3.34e-05	0.27	0.21	Breast cancer;	chr5:149054712	chr5:149062334~149062355:-
BLCA	cis	rs12431410	0.55	rs7154315	MIMAT0022287	hsa-miR-5586-5p	-4.2	3.35e-05	-0.19	-0.21	Schizophrenia;	chr14:59768278	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.514	rs7155725	MIMAT0022287	hsa-miR-5586-5p	-4.2	3.35e-05	-0.19	-0.21	Schizophrenia;	chr14:59769183	chr14:59646999~59647020:-
BLCA	cis	rs6558174	0.965	rs2404655	MIMAT0000510	hsa-miR-320a-3p	4.2	3.4e-05	0.19	0.21	Breast cancer;	chr8:22632696	chr8:22244975~22244996:-
BLCA	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	4.2	3.41e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	4.2	3.41e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	4.2	3.41e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
BLCA	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	4.19	3.43e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
BLCA	cis	rs1018697	0.966	rs1475643	MIMAT0005951	hsa-miR-1307-3p	4.19	3.49e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394301~103394322:-
BLCA	cis	rs32576	0.74	rs32574	MIMAT0000731	hsa-miR-378a-5p	-4.19	3.52e-05	-0.22	-0.21	Obesity-related traits;	chr5:149839323	chr5:149732829~149732850:+
BLCA	cis	rs12431410	0.55	rs10138254	MIMAT0022287	hsa-miR-5586-5p	-4.19	3.54e-05	-0.19	-0.21	Schizophrenia;	chr14:59742470	chr14:59646999~59647020:-
BLCA	cis	rs1729578	0.551	rs1919462	MIMAT0003273	hsa-miR-605-5p	-4.19	3.55e-05	-0.22	-0.21	Alcohol misuse (trauma interaction);	chr10:52225879	chr10:51299588~51299610:+
BLCA	cis	rs950880	0.542	rs1420091	MIMAT0019927	hsa-miR-4772-3p	4.18	3.62e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102300774	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs4399750	MIMAT0019927	hsa-miR-4772-3p	4.18	3.62e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102301328	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs12432408	MIMAT0022287	hsa-miR-5586-5p	-4.18	3.64e-05	-0.19	-0.21	Schizophrenia;	chr14:59728423	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.536	rs11626406	MIMAT0022287	hsa-miR-5586-5p	4.18	3.66e-05	0.2	0.21	Schizophrenia;	chr14:59684738	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs8007780	MIMAT0022287	hsa-miR-5586-5p	-4.18	3.67e-05	-0.19	-0.21	Schizophrenia;	chr14:59731329	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.645	rs56044378	MIMAT0019927	hsa-miR-4772-3p	4.18	3.7e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102448907	chr2:102432336~102432357:+
BLCA	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	4.18	3.7e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	4.18	3.7e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
BLCA	cis	rs950880	0.71	rs4851583	MIMAT0019927	hsa-miR-4772-3p	4.17	3.72e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102443840	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs11694360	MIMAT0019927	hsa-miR-4772-3p	4.17	3.72e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102444687	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs11123928	MIMAT0019927	hsa-miR-4772-3p	4.17	3.72e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102444826	chr2:102432336~102432357:+
BLCA	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	4.17	3.74e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
BLCA	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	4.17	3.74e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
BLCA	cis	rs7917772	0.69	rs11191369	MIMAT0005951	hsa-miR-1307-3p	-4.17	3.75e-05	-0.12	-0.21	Waist-to-hip ratio adjusted for body mass index;White blood cell count;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);	chr10:102697699	chr10:103394301~103394322:-
BLCA	cis	rs1727638	0.522	rs852924	MIMAT0004550	hsa-miR-30c-2-3p	-4.17	3.76e-05	-0.24	-0.21	Cerebrospinal fluid AB1-42 levels;	chr6:71472957	chr6:71376964~71376985:-
BLCA	cis	rs950880	0.668	rs3732126	MIMAT0019927	hsa-miR-4772-3p	4.17	3.8e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102397502	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs3732125	MIMAT0019927	hsa-miR-4772-3p	4.17	3.8e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102397503	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs1135354	MIMAT0019927	hsa-miR-4772-3p	4.17	3.8e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102397842	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	4.17	3.81e-05	0.13	0.21	Migraine;	chr10:103244344	chr10:103394341~103394361:-
BLCA	cis	rs7851726	0.69	rs4743969	MIMAT0019208	hsa-miR-3074-5p	-4.17	3.84e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94836684	chr9:95086063~95086083:-
BLCA	cis	rs7072216	0.77	rs1737	MIMAT0026738	hsa-miR-1287-3p	4.17	3.84e-05	0.16	0.21	Metabolite levels;	chr10:98416609	chr10:98395232~98395253:-
BLCA	cis	rs950880	0.553	rs3755272	MIMAT0019927	hsa-miR-4772-3p	4.17	3.84e-05	0.21	0.21	Serum protein levels (sST2);	chr2:102417365	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.553	rs2293225	MIMAT0019927	hsa-miR-4772-3p	4.17	3.84e-05	0.21	0.21	Serum protein levels (sST2);	chr2:102419429	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs7597017	MIMAT0019927	hsa-miR-4772-3p	4.17	3.86e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102445656	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.677	rs4851585	MIMAT0019927	hsa-miR-4772-3p	4.17	3.86e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102446294	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-4.16	3.88e-05	-0.17	-0.21	Asthma;	chr2:102446466	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	4.16	3.89e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-4.16	3.92e-05	-0.13	-0.21	Migraine;	chr10:103262005	chr10:103394341~103394361:-
BLCA	cis	rs7849420	1	rs7849420	MIMAT0004504	hsa-miR-31-3p	4.16	3.98e-05	0.26	0.21	Lipid traits;	chr9:21499625	chr9:21512121~21512142:-
BLCA	cis	rs12431410	0.536	rs1956373	MIMAT0022287	hsa-miR-5586-5p	4.16	4.01e-05	0.2	0.21	Schizophrenia;	chr14:59675104	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.508	rs1952042	MIMAT0022287	hsa-miR-5586-5p	4.16	4.01e-05	0.2	0.21	Schizophrenia;	chr14:59679630	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.536	rs1952043	MIMAT0022287	hsa-miR-5586-5p	4.16	4.01e-05	0.2	0.21	Schizophrenia;	chr14:59679837	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.71	rs17027071	MIMAT0019927	hsa-miR-4772-3p	4.15	4.05e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102396214	chr2:102432336~102432357:+
BLCA	cis	rs7851726	0.676	rs10821398	MIMAT0019208	hsa-miR-3074-5p	-4.15	4.14e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94815277	chr9:95086063~95086083:-
BLCA	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	4.14	4.21e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.26e-05	-0.13	-0.21	Migraine;	chr10:103284400	chr10:103394341~103394361:-
BLCA	cis	rs950880	0.71	rs17027255	MIMAT0019927	hsa-miR-4772-3p	4.14	4.27e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102473668	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs1420090	MIMAT0019927	hsa-miR-4772-3p	4.13	4.44e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102302845	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs7565653	MIMAT0019927	hsa-miR-4772-3p	4.13	4.44e-05	0.17	0.21	Serum protein levels (sST2);	chr2:102302966	chr2:102432336~102432357:+
BLCA	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	4.13	4.48e-05	0.12	0.21	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.584	rs17096617	MIMAT0022287	hsa-miR-5586-5p	-4.13	4.56e-05	-0.19	-0.21	Schizophrenia;	chr14:59777032	chr14:59646999~59647020:-
BLCA	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-4.12	4.61e-05	-0.17	-0.21	Asthma;	chr2:102446780	chr2:102432336~102432357:+
BLCA	cis	rs7851726	0.652	rs7847277	MIMAT0019208	hsa-miR-3074-5p	-4.12	4.69e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94851146	chr9:95086063~95086083:-
BLCA	cis	rs4988958	0.565	rs3755265	MIMAT0019927	hsa-miR-4772-3p	-4.12	4.71e-05	-0.17	-0.21	Asthma (childhood onset);	chr2:102436356	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.536	rs1957998	MIMAT0022287	hsa-miR-5586-5p	-4.11	4.78e-05	-0.2	-0.21	Schizophrenia;	chr14:59682082	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.677	rs17027087	MIMAT0019927	hsa-miR-4772-3p	4.11	4.83e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102399458	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-4.11	4.85e-05	-0.13	-0.21	Migraine;	chr10:103367521	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-4.11	4.85e-05	-0.13	-0.21	Migraine;	chr10:103379204	chr10:103394341~103394361:-
BLCA	cis	rs950880	0.71	rs55645612	MIMAT0019927	hsa-miR-4772-3p	4.11	4.89e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102439201	chr2:102432336~102432357:+
BLCA	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-4.11	4.92e-05	-0.23	-0.21	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
BLCA	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-4.11	4.92e-05	-0.23	-0.21	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
BLCA	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.11	4.95e-05	-0.13	-0.21	Migraine;	chr10:103367951	chr10:103394341~103394361:-
BLCA	cis	rs7851726	0.646	rs2031698	MIMAT0019208	hsa-miR-3074-5p	-4.11	4.95e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94779050	chr9:95086063~95086083:-
BLCA	cis	rs12431410	0.584	rs7146207	MIMAT0022287	hsa-miR-5586-5p	-4.1	4.98e-05	-0.19	-0.21	Schizophrenia;	chr14:59771144	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.584	rs10498490	MIMAT0022287	hsa-miR-5586-5p	-4.1	4.98e-05	-0.19	-0.21	Schizophrenia;	chr14:59774719	chr14:59646999~59647020:-
BLCA	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	4.1	4.99e-05	0.17	0.21	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs66919607	MIMAT0019927	hsa-miR-4772-3p	4.1	5.13e-05	0.19	0.21	Serum protein levels (sST2);	chr2:102392509	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs28529862	MIMAT0022287	hsa-miR-5586-5p	-4.09	5.2e-05	-0.19	-0.21	Schizophrenia;	chr14:59714780	chr14:59646999~59647020:-
BLCA	cis	rs7851726	0.646	rs10739983	MIMAT0019208	hsa-miR-3074-5p	-4.09	5.26e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94764002	chr9:95086063~95086083:-
BLCA	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-4.09	5.27e-05	-0.13	-0.21	Migraine;	chr10:103386935	chr10:103394341~103394361:-
BLCA	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-4.09	5.3e-05	-0.19	-0.21	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
BLCA	cis	rs12431410	0.55	rs1952037	MIMAT0022287	hsa-miR-5586-5p	-4.09	5.3e-05	-0.18	-0.21	Schizophrenia;	chr14:59713276	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.536	rs11622268	MIMAT0022287	hsa-miR-5586-5p	4.09	5.3e-05	0.2	0.21	Schizophrenia;	chr14:59684790	chr14:59646999~59647020:-
BLCA	cis	rs8064299	0.967	rs878907	MIMAT0017994	hsa-miR-3615	-4.09	5.35e-05	-0.19	-0.21	Monocyte count;	chr17:74773555	chr17:74748663~74748683:+
BLCA	cis	rs74233809	1	rs11191472	MIMAT0005951	hsa-miR-1307-3p	-4.09	5.39e-05	-0.18	-0.21	Birth weight;	chr10:102947259	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs10883806	MIMAT0005951	hsa-miR-1307-3p	-4.09	5.39e-05	-0.18	-0.21	Birth weight;	chr10:102953319	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs78260931	MIMAT0005951	hsa-miR-1307-3p	-4.09	5.39e-05	-0.18	-0.21	Birth weight;	chr10:102962205	chr10:103394301~103394322:-
BLCA	cis	rs8064299	0.967	rs878906	MIMAT0017994	hsa-miR-3615	-4.08	5.46e-05	-0.19	-0.21	Monocyte count;	chr17:74773195	chr17:74748663~74748683:+
BLCA	cis	rs8064299	0.967	rs878905	MIMAT0017994	hsa-miR-3615	-4.08	5.46e-05	-0.19	-0.21	Monocyte count;	chr17:74773272	chr17:74748663~74748683:+
BLCA	cis	rs32576	0.74	rs32575	MIMAT0000731	hsa-miR-378a-5p	-4.08	5.47e-05	-0.21	-0.21	Obesity-related traits;	chr5:149835650	chr5:149732829~149732850:+
BLCA	cis	rs7851726	0.69	rs7027708	MIMAT0019208	hsa-miR-3074-5p	-4.08	5.54e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94748390	chr9:95086063~95086083:-
BLCA	cis	rs7851726	0.646	rs10821393	MIMAT0019208	hsa-miR-3074-5p	-4.08	5.54e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94754478	chr9:95086063~95086083:-
BLCA	cis	rs950880	0.56	rs12476968	MIMAT0019927	hsa-miR-4772-3p	4.08	5.57e-05	0.16	0.21	Serum protein levels (sST2);	chr2:102308202	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs12476925	MIMAT0019927	hsa-miR-4772-3p	4.08	5.58e-05	0.16	0.21	Serum protein levels (sST2);	chr2:102308089	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.542	rs7568913	MIMAT0019927	hsa-miR-4772-3p	4.08	5.59e-05	0.16	0.21	Serum protein levels (sST2);	chr2:102303577	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.542	rs10179654	MIMAT0019927	hsa-miR-4772-3p	4.08	5.59e-05	0.16	0.21	Serum protein levels (sST2);	chr2:102305323	chr2:102432336~102432357:+
BLCA	cis	rs7851726	0.69	rs4744386	MIMAT0019208	hsa-miR-3074-5p	-4.08	5.59e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94852359	chr9:95086063~95086083:-
BLCA	cis	rs950880	0.71	rs17027179	MIMAT0019927	hsa-miR-4772-3p	4.07	5.63e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102440699	chr2:102432336~102432357:+
BLCA	cis	rs7851726	0.69	rs10821392	MIMAT0019208	hsa-miR-3074-5p	-4.07	5.66e-05	-0.16	-0.21	Urinary albumin-to-creatinine ratio;	chr9:94746625	chr9:95086063~95086083:-
BLCA	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	4.07	5.78e-05	0.16	0.21	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.548	rs35879984	MIMAT0022287	hsa-miR-5586-5p	-4.07	5.79e-05	-0.19	-0.21	Schizophrenia;	chr14:59777497	chr14:59646999~59647020:-
BLCA	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	4.07	5.8e-05	0.17	0.21	Asthma;	chr2:102394777	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs11844387	MIMAT0022287	hsa-miR-5586-5p	-4.07	5.83e-05	-0.18	-0.21	Schizophrenia;	chr14:59758006	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.71	rs2270298	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102375619	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs17027037	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102378424	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs2080289	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102378560	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs11683700	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102380345	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs3821203	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102380412	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs3771162	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102380714	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs11465633	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102381273	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs56258475	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102382852	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs1035130	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102384942	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs4851570	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102389927	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs17027060	MIMAT0019927	hsa-miR-4772-3p	4.07	5.83e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102391107	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs10151833	MIMAT0022287	hsa-miR-5586-5p	-4.07	5.85e-05	-0.18	-0.21	Schizophrenia;	chr14:59712216	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.71	rs56166614	MIMAT0019927	hsa-miR-4772-3p	4.06	5.95e-05	0.18	0.21	Serum protein levels (sST2);	chr2:102439636	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-4.06	5.97e-05	-0.12	-0.21	Migraine;	chr10:103293183	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-4.06	5.97e-05	-0.12	-0.21	Migraine;	chr10:103293219	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs7159057	MIMAT0022287	hsa-miR-5586-5p	-4.06	6.06e-05	-0.18	-0.21	Schizophrenia;	chr14:59742694	chr14:59646999~59647020:-
BLCA	cis	rs950880	0.71	rs11123927	MIMAT0019927	hsa-miR-4772-3p	4.05	6.11e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102442343	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs10490203	MIMAT0019927	hsa-miR-4772-3p	4.05	6.11e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102442777	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs13021177	MIMAT0019927	hsa-miR-4772-3p	-4.05	6.18e-05	-0.16	-0.2	Asthma;	chr2:102440033	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	4.05	6.34e-05	0.16	0.2	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
BLCA	cis	rs4851551	0.543	rs11903354	MIMAT0019927	hsa-miR-4772-3p	-4.05	6.34e-05	-0.27	-0.2	Blood protein levels;	chr2:102193968	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs56043441	MIMAT0019927	hsa-miR-4772-3p	4.03	6.67e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102470923	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	4.03	6.67e-05	0.16	0.2	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
BLCA	cis	rs8064299	0.934	rs895692	MIMAT0017994	hsa-miR-3615	-4.03	6.67e-05	-0.19	-0.2	Monocyte count;	chr17:74770113	chr17:74748663~74748683:+
BLCA	cis	rs2819332	0.639	rs882464	MIMAT0027369	hsa-miR-6734-5p	-4.03	6.79e-05	-0.23	-0.2	Amyotrophic lateral sclerosis (age of onset);	chr1:43509093	chr1:43364688~43364710:-
BLCA	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-4.03	6.83e-05	-0.12	-0.2	Migraine;	chr10:103367951	chr10:103394301~103394322:-
BLCA	cis	rs1443512	0.588	rs1975473	MIMAT0000759	hsa-miR-148b-3p	4.03	6.88e-05	0.19	0.2	Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction);Waist-to-hip ratio adjusted for BMI in non-smokers;Waist-hip ratio;	chr12:53940841	chr12:54337278~54337299:+
BLCA	cis	rs7849420	1	rs7849420	MIMAT0000089	hsa-miR-31-5p	4.03	6.88e-05	0.25	0.2	Lipid traits;	chr9:21499625	chr9:21512158~21512178:-
BLCA	cis	rs950880	0.593	rs887972	MIMAT0019927	hsa-miR-4772-3p	4.02	6.91e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102424485	chr2:102432336~102432357:+
BLCA	cis	rs62560775	0.541	rs12352425	MIMAT0004504	hsa-miR-31-3p	4.02	6.92e-05	0.34	0.2	Lung cancer;Lung adenocarcinoma;	chr9:22042087	chr9:21512121~21512142:-
BLCA	cis	rs950880	0.71	rs2287034	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.95e-05	-0.18	-0.2	Serum protein levels (sST2);	chr2:102394128	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.584	rs17096614	MIMAT0022287	hsa-miR-5586-5p	4.02	6.98e-05	0.18	0.2	Schizophrenia;	chr14:59776876	chr14:59646999~59647020:-
BLCA	cis	rs7868228	1	rs10119803	MIMAT0000089	hsa-miR-31-5p	-4.02	7.06e-05	-0.28	-0.2	Gut microbiome composition (winter);	chr9:21666067	chr9:21512158~21512178:-
BLCA	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-4.02	7.07e-05	-0.12	-0.2	Migraine;	chr10:103395309	chr10:103394301~103394322:-
BLCA	cis	rs950880	0.71	rs56117144	MIMAT0019927	hsa-miR-4772-3p	4.02	7.14e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102458191	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs57081652	MIMAT0019927	hsa-miR-4772-3p	4.02	7.14e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102458921	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.01	7.2e-05	-0.13	-0.2	Migraine;	chr10:103384531	chr10:103394341~103394361:-
BLCA	cis	rs1727638	0.522	rs4141421	MIMAT0004550	hsa-miR-30c-2-3p	4.01	7.32e-05	0.24	0.2	Cerebrospinal fluid AB1-42 levels;	chr6:71476768	chr6:71376964~71376985:-
BLCA	cis	rs950880	0.56	rs2110660	MIMAT0019927	hsa-miR-4772-3p	4.01	7.41e-05	0.16	0.2	Serum protein levels (sST2);	chr2:102302141	chr2:102432336~102432357:+
BLCA	cis	rs1950626	0.699	rs12896504	MIMAT0022928	hsa-miR-376a-2-5p	-4	7.48e-05	-0.24	-0.2	Pelvic organ prolapse (moderate/severe);	chr14:101001611	chr14:101040080~101040100:+
BLCA	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-4	7.53e-05	-0.13	-0.2	Migraine;	chr10:103278698	chr10:103394341~103394361:-
BLCA	cis	rs950880	0.553	rs2241116	MIMAT0019927	hsa-miR-4772-3p	4	7.56e-05	0.2	0.2	Serum protein levels (sST2);	chr2:102386805	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	4	7.58e-05	0.17	0.2	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.782	rs9323353	MIMAT0022287	hsa-miR-5586-5p	-4	7.62e-05	-0.19	-0.2	Schizophrenia;	chr14:59704329	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-4	7.63e-05	-0.13	-0.2	Migraine;	chr10:103395888	chr10:103394341~103394361:-
BLCA	cis	rs12431410	0.584	rs17096618	MIMAT0022287	hsa-miR-5586-5p	-3.99	7.79e-05	-0.18	-0.2	Schizophrenia;	chr14:59777473	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-3.99	7.82e-05	-0.13	-0.2	Migraine;	chr10:103395309	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.82e-05	-0.12	-0.2	Migraine;	chr10:103367521	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.82e-05	-0.12	-0.2	Migraine;	chr10:103379204	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs11191531	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.85e-05	-0.18	-0.2	Birth weight;	chr10:103047141	chr10:103394301~103394322:-
BLCA	cis	rs74233809	0.748	rs10786736	MIMAT0005951	hsa-miR-1307-3p	-3.99	7.87e-05	-0.17	-0.2	Birth weight;	chr10:103089359	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	3.99	7.9e-05	0.13	0.2	Migraine;	chr10:103261506	chr10:103394341~103394361:-
BLCA	cis	rs950880	0.71	rs17027258	MIMAT0019927	hsa-miR-4772-3p	3.99	7.91e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102475081	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs4851011	MIMAT0019927	hsa-miR-4772-3p	-3.99	8.01e-05	-0.18	-0.2	Serum protein levels (sST2);	chr2:102473219	chr2:102432336~102432357:+
BLCA	cis	rs7851726	0.69	rs11788697	MIMAT0019208	hsa-miR-3074-5p	-3.99	8.03e-05	-0.16	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94823083	chr9:95086063~95086083:-
BLCA	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-3.99	8.07e-05	-0.12	-0.2	Migraine;	chr10:103395888	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.15e-05	-0.13	-0.2	Migraine;	chr10:103358719	chr10:103394341~103394361:-
BLCA	cis	rs12431410	0.55	rs9323354	MIMAT0022287	hsa-miR-5586-5p	-3.98	8.15e-05	-0.18	-0.2	Schizophrenia;	chr14:59718017	chr14:59646999~59647020:-
BLCA	cis	rs7072216	0.77	rs1739	MIMAT0026738	hsa-miR-1287-3p	3.98	8.23e-05	0.16	0.2	Metabolite levels;	chr10:98416582	chr10:98395232~98395253:-
BLCA	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.23e-05	-0.13	-0.2	Migraine;	chr10:103297804	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.28e-05	-0.13	-0.2	Migraine;	chr10:103348698	chr10:103394341~103394361:-
BLCA	cis	rs74233809	1	rs79668541	MIMAT0005951	hsa-miR-1307-3p	-3.98	8.29e-05	-0.18	-0.2	Birth weight;	chr10:103034147	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.33e-05	-0.13	-0.2	Migraine;	chr10:103353944	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.33e-05	-0.13	-0.2	Migraine;	chr10:103356299	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-3.98	8.33e-05	-0.13	-0.2	Migraine;	chr10:103358705	chr10:103394341~103394361:-
BLCA	cis	rs7851726	0.624	rs12338859	MIMAT0019208	hsa-miR-3074-5p	3.98	8.39e-05	0.16	0.2	Urinary albumin-to-creatinine ratio;	chr9:94901338	chr9:95086063~95086083:-
BLCA	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-3.98	8.43e-05	-0.28	-0.2	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
BLCA	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-3.97	8.53e-05	-0.12	-0.2	Migraine;	chr10:103386935	chr10:103394301~103394322:-
BLCA	cis	rs4851551	0.543	rs35918372	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.55e-05	-0.29	-0.2	Blood protein levels;	chr2:102202803	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-3.97	8.62e-05	-0.13	-0.2	Migraine;	chr10:103270083	chr10:103394341~103394361:-
BLCA	cis	rs12431410	0.892	rs7149112	MIMAT0022287	hsa-miR-5586-5p	3.97	8.72e-05	0.18	0.2	Schizophrenia;	chr14:59688589	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-3.96	8.88e-05	-0.12	-0.2	Migraine;	chr10:103353944	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-3.96	8.88e-05	-0.12	-0.2	Migraine;	chr10:103356299	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-3.96	8.88e-05	-0.12	-0.2	Migraine;	chr10:103358705	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs3781285	MIMAT0005951	hsa-miR-1307-3p	-3.96	8.98e-05	-0.18	-0.2	Birth weight;	chr10:103065908	chr10:103394301~103394322:-
BLCA	cis	rs1219407	0.881	rs1789847	MIMAT0000423	hsa-miR-125b-5p	-3.96	9.02e-05	-0.22	-0.2	Mood disorder in prion disease;	chr11:121862295	chr11:122099809~122099830:-
BLCA	cis	rs1219407	0.881	rs1789847	MIMAT0000423_1	hsa-miR-125b-5p	-3.96	9.02e-05	-0.22	-0.2	Mood disorder in prion disease;	chr11:121862295	chr21:16590253~16590274:+
BLCA	cis	rs74233809	1	rs11191515	MIMAT0005951	hsa-miR-1307-3p	-3.96	9.07e-05	-0.18	-0.2	Birth weight;	chr10:103016770	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-3.96	9.08e-05	-0.12	-0.2	Migraine;	chr10:103384531	chr10:103394301~103394322:-
BLCA	cis	rs32576	0.74	rs26121	MIMAT0000731	hsa-miR-378a-5p	-3.96	9.1e-05	-0.22	-0.2	Obesity-related traits;	chr5:149852267	chr5:149732829~149732850:+
BLCA	cis	rs7649443	0.759	rs12632536	MIMAT0019973	hsa-miR-4797-3p	3.96	9.13e-05	0.26	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197106779	chr3:197293888~197293908:-
BLCA	cis	rs11037575	0.966	rs2863002	MIMAT0004605	hsa-miR-129-2-3p	-3.95	9.28e-05	-0.25	-0.2	Neuroblastoma;	chr11:43693218	chr11:43581450~43581471:+
BLCA	cis	rs1163656	0.572	rs7303026	MIMAT0003287	hsa-miR-618	-3.95	9.36e-05	-0.28	-0.2	Dental caries;	chr12:80921967	chr12:80935796~80935818:-
BLCA	cis	rs1163656	0.572	rs7134652	MIMAT0003287	hsa-miR-618	-3.95	9.36e-05	-0.28	-0.2	Dental caries;	chr12:80922054	chr12:80935796~80935818:-
BLCA	cis	rs1163656	0.572	rs7134827	MIMAT0003287	hsa-miR-618	-3.95	9.36e-05	-0.28	-0.2	Dental caries;	chr12:80922229	chr12:80935796~80935818:-
BLCA	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	3.94	9.55e-05	0.16	0.2	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs3771150	MIMAT0019927	hsa-miR-4772-3p	3.94	9.57e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102444391	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs2293224	MIMAT0019927	hsa-miR-4772-3p	-3.94	9.63e-05	-0.16	-0.2	Asthma;	chr2:102419319	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs6743516	MIMAT0019927	hsa-miR-4772-3p	-3.94	9.63e-05	-0.16	-0.2	Asthma;	chr2:102419875	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.565	rs1420100	MIMAT0019927	hsa-miR-4772-3p	-3.94	9.63e-05	-0.16	-0.2	Asthma (childhood onset);	chr2:102420542	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.527	rs3771155	MIMAT0019927	hsa-miR-4772-3p	-3.94	9.63e-05	-0.16	-0.2	Asthma (childhood onset);	chr2:102421366	chr2:102432336~102432357:+
BLCA	cis	rs17214007	0.877	rs2075515	MIMAT0002174	hsa-miR-484	3.93	9.92e-05	0.22	0.2	Cognitive function;	chr16:15778462	chr16:15643301~15643322:+
BLCA	cis	rs2069426	0.73	rs115939893	MIMAT0004504	hsa-miR-31-3p	-3.93	1e-04	-0.39	-0.2	Acute lymphoblastic leukemia (childhood);	chr9:22054822	chr9:21512121~21512142:-
BLCA	cis	rs2819332	0.639	rs10789434	MIMAT0027369	hsa-miR-6734-5p	3.93	1e-04	0.23	0.2	Amyotrophic lateral sclerosis (age of onset);	chr1:43510950	chr1:43364688~43364710:-
BLCA	cis	rs7649443	0.759	rs3903682	MIMAT0019973	hsa-miR-4797-3p	-3.93	0.000101	-0.25	-0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197280675	chr3:197293888~197293908:-
BLCA	cis	rs6703335	0.544	rs4658558	MIMAT0019761	hsa-miR-4677-3p	3.93	0.000101	0.17	0.2	Schizophrenia;Schizophrenia, schizoaffective disorder or bipolar disorder;	chr1:243342539	chr1:243346225~243346246:+
BLCA	cis	rs12431410	0.55	rs9323355	MIMAT0022287	hsa-miR-5586-5p	-3.93	0.000101	-0.18	-0.2	Schizophrenia;	chr14:59719642	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000101	-0.11	-0.2	Migraine;	chr10:103358719	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000102	-0.12	-0.2	Migraine;	chr10:103299551	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000102	-0.11	-0.2	Migraine;	chr10:103317367	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000102	-0.11	-0.2	Migraine;	chr10:103319682	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs75970938	MIMAT0005951	hsa-miR-1307-3p	-3.93	0.000103	-0.18	-0.2	Birth weight;	chr10:103033891	chr10:103394301~103394322:-
BLCA	cis	rs950880	0.71	rs55927292	MIMAT0019927	hsa-miR-4772-3p	3.92	0.000103	0.18	0.2	Serum protein levels (sST2);	chr2:102348401	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs2287035	MIMAT0019927	hsa-miR-4772-3p	3.92	0.000103	0.18	0.2	Serum protein levels (sST2);	chr2:102394070	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-3.92	0.000106	-0.11	-0.2	Migraine;	chr10:103348698	chr10:103394301~103394322:-
BLCA	cis	rs7224314	1	rs7221926	MIMAT0003323	hsa-miR-548d-3p	-3.92	0.000106	-0.25	-0.2	Diisocyanate-induced asthma;	chr17:67356065	chr17:67471504~67471525:-
BLCA	cis	rs7224314	1	rs7221926	MIMAT0003323_1	hsa-miR-548d-3p	-3.92	0.000106	-0.25	-0.2	Diisocyanate-induced asthma;	chr17:67356065	chr8:123348049~123348070:-
BLCA	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-3.92	0.000107	-0.11	-0.2	Migraine;	chr10:103309363	chr10:103394301~103394322:-
BLCA	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-3.92	0.000107	-0.16	-0.2	Asthma;	chr2:102399227	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs10151510	MIMAT0022287	hsa-miR-5586-5p	-3.92	0.000107	-0.18	-0.2	Schizophrenia;	chr14:59715138	chr14:59646999~59647020:-
BLCA	cis	rs10216189	1	rs7799665	MIMAT0003256	hsa-miR-589-3p	-3.91	0.000108	-0.17	-0.2	Relative hand skill in reading disability;	chr7:5487870	chr7:5495834~5495857:-
BLCA	cis	rs12431410	0.55	rs10136152	MIMAT0022287	hsa-miR-5586-5p	-3.91	0.000108	-0.18	-0.2	Schizophrenia;	chr14:59729435	chr14:59646999~59647020:-
BLCA	cis	rs7035284	1	rs7028950	MIMAT0000089	hsa-miR-31-5p	-3.91	0.000108	-0.26	-0.2	Pediatric bone mineral content (radius);	chr9:21682261	chr9:21512158~21512178:-
BLCA	cis	rs12431410	0.55	rs1957995	MIMAT0022287	hsa-miR-5586-5p	-3.91	0.000108	-0.18	-0.2	Schizophrenia;	chr14:59732850	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.55	rs8014898	MIMAT0022287	hsa-miR-5586-5p	-3.91	0.000108	-0.18	-0.2	Schizophrenia;	chr14:59734296	chr14:59646999~59647020:-
BLCA	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	3.91	0.000108	0.12	0.2	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
BLCA	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000109	-0.18	-0.2	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs943037	MIMAT0005951	hsa-miR-1307-3p	-3.91	0.00011	-0.18	-0.2	Birth weight;	chr10:103076162	chr10:103394301~103394322:-
BLCA	cis	rs9807989	0.507	rs6710528	MIMAT0019927	hsa-miR-4772-3p	3.91	0.000111	0.16	0.2	Asthma;	chr2:102399682	chr2:102432336~102432357:+
BLCA	cis	rs4253772	0.55	rs6008615	MIMAT0000063	hsa-let-7b-5p	-3.9	0.000112	-0.35	-0.2	Cholesterol, total;LDL cholesterol;	chr22:46312031	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.53	rs6008623	MIMAT0000063	hsa-let-7b-5p	-3.9	0.000112	-0.35	-0.2	Cholesterol, total;LDL cholesterol;	chr22:46314127	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.591	rs7286155	MIMAT0000063	hsa-let-7b-5p	-3.9	0.000112	-0.35	-0.2	Cholesterol, total;LDL cholesterol;	chr22:46318838	chr22:46113691~46113712:+
BLCA	cis	rs4851551	0.543	rs35918372	MIMAT0019926	hsa-miR-4772-5p	3.9	0.000113	0.34	0.2	Blood protein levels;	chr2:102202803	chr2:102432300~102432321:+
BLCA	cis	rs7868228	1	rs7868333	MIMAT0000089	hsa-miR-31-5p	-3.9	0.000113	-0.28	-0.2	Gut microbiome composition (winter);	chr9:21667826	chr9:21512158~21512178:-
BLCA	cis	rs74233809	1	rs12412038	MIMAT0005951	hsa-miR-1307-3p	-3.9	0.000114	-0.18	-0.2	Birth weight;	chr10:103096405	chr10:103394301~103394322:-
BLCA	cis	rs7868228	1	rs10119803	MIMAT0004504	hsa-miR-31-3p	-3.9	0.000114	-0.27	-0.2	Gut microbiome composition (winter);	chr9:21666067	chr9:21512121~21512142:-
BLCA	cis	rs10216189	1	rs7799970	MIMAT0003256	hsa-miR-589-3p	-3.9	0.000114	-0.17	-0.2	Relative hand skill in reading disability;	chr7:5488083	chr7:5495834~5495857:-
BLCA	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000114	-0.16	-0.2	Asthma;	chr2:102402540	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000114	-0.16	-0.2	Asthma;	chr2:102402571	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000114	-0.16	-0.2	Asthma;	chr2:102403325	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000114	-0.16	-0.2	Asthma;	chr2:102403679	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000114	-0.16	-0.2	Asthma;	chr2:102404807	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000115	-0.16	-0.2	Asthma;	chr2:102407218	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs11191548	MIMAT0005951	hsa-miR-1307-3p	3.9	0.000115	0.18	0.2	Birth weight;	chr10:103086421	chr10:103394301~103394322:-
BLCA	cis	rs2302612	0.718	rs6742931	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000116	-0.17	-0.2	Serum protein levels (sST2);	chr2:102234783	chr2:102432336~102432357:+
BLCA	cis	rs4851551	0.543	rs62156407	MIMAT0019927	hsa-miR-4772-3p	-3.9	0.000116	-0.29	-0.2	Blood protein levels;	chr2:102208162	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.55	rs7147135	MIMAT0022287	hsa-miR-5586-5p	-3.89	0.000117	-0.18	-0.2	Schizophrenia;	chr14:59740847	chr14:59646999~59647020:-
BLCA	cis	rs7649443	0.759	rs6805920	MIMAT0019973	hsa-miR-4797-3p	3.89	0.000118	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197235458	chr3:197293888~197293908:-
BLCA	cis	rs74233809	1	rs79237883	MIMAT0005951	hsa-miR-1307-3p	-3.89	0.000118	-0.18	-0.2	Birth weight;	chr10:103181189	chr10:103394301~103394322:-
BLCA	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	3.88	0.000121	0.11	0.2	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs77860422	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000122	-0.17	-0.2	Birth weight;	chr10:102988252	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs10883815	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000123	-0.17	-0.2	Birth weight;	chr10:102979422	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs112390216	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000123	-0.17	-0.2	Birth weight;	chr10:102981274	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.536	rs1952033	MIMAT0022287	hsa-miR-5586-5p	3.88	0.000124	0.19	0.2	Schizophrenia;	chr14:59685527	chr14:59646999~59647020:-
BLCA	cis	rs74233809	1	rs11191555	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103097766	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs11191557	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103104857	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs11191558	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103104921	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs12413046	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103111447	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs10883832	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103111522	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs79082900	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103117545	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs12220375	MIMAT0005951	hsa-miR-1307-3p	-3.88	0.000124	-0.18	-0.2	Birth weight;	chr10:103141734	chr10:103394301~103394322:-
BLCA	cis	rs7868228	1	rs7868228	MIMAT0000089	hsa-miR-31-5p	3.88	0.000125	0.27	0.2	Gut microbiome composition (winter);	chr9:21667763	chr9:21512158~21512178:-
BLCA	cis	rs2069426	0.591	rs17694493	MIMAT0000089	hsa-miR-31-5p	3.88	0.000126	0.29	0.2	Acute lymphoblastic leukemia (childhood);	chr9:22041999	chr9:21512158~21512178:-
BLCA	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000126	-0.16	-0.2	Asthma;	chr2:102431747	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000126	-0.16	-0.2	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000126	-0.16	-0.2	Asthma;	chr2:102432120	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000126	-0.16	-0.2	Asthma;	chr2:102432614	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-3.87	0.000126	-0.16	-0.2	Asthma;	chr2:102433405	chr2:102432336~102432357:+
BLCA	cis	rs7210990	0.724	rs2324142	MIMAT0005942	hsa-miR-1288-3p	-3.87	0.000127	-0.2	-0.2	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16137992	chr17:16282058~16282078:+
BLCA	cis	rs7649443	0.704	rs34381158	MIMAT0019973	hsa-miR-4797-3p	3.87	0.000128	0.25	0.2	Nonsyndromic cleft lip with cleft palate;	chr3:197219776	chr3:197293888~197293908:-
BLCA	cis	rs1727638	0.522	rs852920	MIMAT0004550	hsa-miR-30c-2-3p	3.86	0.000131	0.23	0.2	Cerebrospinal fluid AB1-42 levels;	chr6:71475548	chr6:71376964~71376985:-
BLCA	cis	rs12431410	0.536	rs2182139	MIMAT0022287	hsa-miR-5586-5p	-3.86	0.000132	-0.19	-0.2	Schizophrenia;	chr14:59682515	chr14:59646999~59647020:-
BLCA	cis	rs1727638	0.522	rs852919	MIMAT0004550	hsa-miR-30c-2-3p	3.86	0.000133	0.23	0.2	Cerebrospinal fluid AB1-42 levels;	chr6:71476100	chr6:71376964~71376985:-
BLCA	cis	rs2819332	0.639	rs2819341	MIMAT0027369	hsa-miR-6734-5p	-3.86	0.000133	-0.23	-0.2	Amyotrophic lateral sclerosis (age of onset);	chr1:43510486	chr1:43364688~43364710:-
BLCA	cis	rs32576	0.74	rs26127	MIMAT0000731	hsa-miR-378a-5p	3.86	0.000133	0.2	0.2	Obesity-related traits;	chr5:149842225	chr5:149732829~149732850:+
BLCA	cis	rs12431410	0.615	rs10148684	MIMAT0022287	hsa-miR-5586-5p	3.86	0.000135	0.18	0.2	Schizophrenia;	chr14:59664643	chr14:59646999~59647020:-
BLCA	cis	rs1727638	0.747	rs7738323	MIMAT0004550	hsa-miR-30c-2-3p	3.86	0.000135	0.22	0.2	Cerebrospinal fluid AB1-42 levels;	chr6:71416623	chr6:71376964~71376985:-
BLCA	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-3.85	0.000139	-0.16	-0.19	Asthma;	chr2:102410644	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs12217501	MIMAT0005951	hsa-miR-1307-3p	-3.85	0.00014	-0.18	-0.19	Birth weight;	chr10:103092132	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-3.85	0.000141	-0.12	-0.19	Migraine;	chr10:103375562	chr10:103394341~103394361:-
BLCA	cis	rs7649443	0.842	rs6797085	MIMAT0019973	hsa-miR-4797-3p	3.84	0.000143	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197221457	chr3:197293888~197293908:-
BLCA	cis	rs1727638	0.522	rs852962	MIMAT0004550	hsa-miR-30c-2-3p	3.84	0.000143	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71477911	chr6:71376964~71376985:-
BLCA	cis	rs7868228	1	rs7868333	MIMAT0004504	hsa-miR-31-3p	-3.84	0.000144	-0.28	-0.19	Gut microbiome composition (winter);	chr9:21667826	chr9:21512121~21512142:-
BLCA	cis	rs12431410	0.536	rs2182140	MIMAT0022287	hsa-miR-5586-5p	-3.84	0.000146	-0.19	-0.19	Schizophrenia;	chr14:59682541	chr14:59646999~59647020:-
BLCA	cis	rs4988958	0.565	rs10206291	MIMAT0019927	hsa-miR-4772-3p	-3.84	0.000146	-0.16	-0.19	Asthma (childhood onset);	chr2:102422403	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.565	rs3771154	MIMAT0019927	hsa-miR-4772-3p	-3.84	0.000146	-0.16	-0.19	Asthma (childhood onset);	chr2:102422900	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.524	rs6759479	MIMAT0019927	hsa-miR-4772-3p	-3.84	0.000146	-0.16	-0.19	Asthma;	chr2:102423587	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-3.84	0.000146	-0.12	-0.19	Migraine;	chr10:103389790	chr10:103394341~103394361:-
BLCA	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-3.84	0.000146	-0.16	-0.19	Asthma;	chr2:102418383	chr2:102432336~102432357:+
BLCA	cis	rs7649443	0.759	rs36035383	MIMAT0019973	hsa-miR-4797-3p	3.84	0.000147	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197243260	chr3:197293888~197293908:-
BLCA	cis	rs7649443	0.759	rs13066853	MIMAT0019973	hsa-miR-4797-3p	3.83	0.000147	0.25	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197180445	chr3:197293888~197293908:-
BLCA	cis	rs4253772	0.55	rs6007819	MIMAT0000063	hsa-let-7b-5p	-3.83	0.000147	-0.34	-0.19	Cholesterol, total;LDL cholesterol;	chr22:46309019	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.55	rs12165597	MIMAT0000063	hsa-let-7b-5p	-3.83	0.000147	-0.34	-0.19	Cholesterol, total;LDL cholesterol;	chr22:46309687	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.55	rs6008613	MIMAT0000063	hsa-let-7b-5p	-3.83	0.000147	-0.34	-0.19	Cholesterol, total;LDL cholesterol;	chr22:46312027	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.53	rs6008616	MIMAT0000063	hsa-let-7b-5p	-3.83	0.000147	-0.34	-0.19	Cholesterol, total;LDL cholesterol;	chr22:46312057	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.513	rs12171124	MIMAT0000063	hsa-let-7b-5p	-3.83	0.000147	-0.34	-0.19	Cholesterol, total;LDL cholesterol;	chr22:46314796	chr22:46113691~46113712:+
BLCA	cis	rs4253772	0.55	rs6007830	MIMAT0000063	hsa-let-7b-5p	-3.83	0.000147	-0.34	-0.19	Cholesterol, total;LDL cholesterol;	chr22:46315426	chr22:46113691~46113712:+
BLCA	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	3.83	0.00015	0.16	0.19	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
BLCA	cis	rs950880	0.71	rs10490204	MIMAT0019927	hsa-miR-4772-3p	3.83	0.00015	0.18	0.19	Serum protein levels (sST2);	chr2:102440074	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000151	-0.15	-0.19	Asthma;	chr2:102411180	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000151	-0.15	-0.19	Asthma;	chr2:102411191	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000151	-0.15	-0.19	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000151	-0.15	-0.19	Asthma;	chr2:102415109	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000151	-0.15	-0.19	Asthma;	chr2:102415289	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000151	-0.15	-0.19	Asthma;	chr2:102417501	chr2:102432336~102432357:+
BLCA	cis	rs6537837	0.701	rs2304355	MIMAT0000227	hsa-miR-197-3p	-3.83	0.000151	-0.18	-0.19	Major depressive disorder;	chr1:109612902	chr1:109598940~109598961:+
BLCA	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	3.83	0.000151	0.17	0.19	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-3.83	0.000151	-0.16	-0.19	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
BLCA	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-3.83	0.000152	-0.16	-0.19	Asthma;	chr2:102423717	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs11191505	MIMAT0005951	hsa-miR-1307-3p	-3.83	0.000153	-0.17	-0.19	Birth weight;	chr10:103007134	chr10:103394301~103394322:-
BLCA	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000154	-0.16	-0.19	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-3.82	0.000155	-0.16	-0.19	Asthma;	chr2:102394452	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.892	rs1957986	MIMAT0022287	hsa-miR-5586-5p	3.82	0.000155	0.17	0.19	Schizophrenia;	chr14:59691447	chr14:59646999~59647020:-
BLCA	cis	rs74233809	1	rs10509759	MIMAT0005951	hsa-miR-1307-3p	-3.82	0.000156	-0.17	-0.19	Birth weight;	chr10:102929908	chr10:103394301~103394322:-
BLCA	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	3.82	0.000156	0.24	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
BLCA	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	3.82	0.000156	0.24	0.19	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
BLCA	cis	rs1727638	0.743	rs199639	MIMAT0004550	hsa-miR-30c-2-3p	3.82	0.000157	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71526745	chr6:71376964~71376985:-
BLCA	cis	rs1950626	0.699	rs12880855	MIMAT0022928	hsa-miR-376a-2-5p	3.82	0.000158	0.23	0.19	Pelvic organ prolapse (moderate/severe);	chr14:101002045	chr14:101040080~101040100:+
BLCA	cis	rs74233809	1	rs11191499	MIMAT0005951	hsa-miR-1307-3p	-3.82	0.000159	-0.17	-0.19	Birth weight;	chr10:103004514	chr10:103394301~103394322:-
BLCA	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	3.82	0.000159	0.15	0.19	Asthma;	chr2:102377873	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.615	rs7160227	MIMAT0022287	hsa-miR-5586-5p	-3.81	0.000159	-0.18	-0.19	Schizophrenia;	chr14:59673121	chr14:59646999~59647020:-
BLCA	cis	rs1950626	0.743	rs12889283	MIMAT0022928	hsa-miR-376a-2-5p	3.81	0.00016	0.23	0.19	Pelvic organ prolapse (moderate/severe);	chr14:100999664	chr14:101040080~101040100:+
BLCA	cis	rs7851726	0.69	rs7848139	MIMAT0019208	hsa-miR-3074-5p	-3.81	0.000162	-0.15	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94733185	chr9:95086063~95086083:-
BLCA	cis	rs7072216	0.77	rs3830020	MIMAT0026738	hsa-miR-1287-3p	-3.81	0.000164	-0.15	-0.19	Metabolite levels;	chr10:98416858	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.55	rs1957994	MIMAT0022287	hsa-miR-5586-5p	-3.8	0.000166	-0.17	-0.19	Schizophrenia;	chr14:59729516	chr14:59646999~59647020:-
BLCA	cis	rs74233809	1	rs10883808	MIMAT0005951	hsa-miR-1307-3p	-3.8	0.00017	-0.17	-0.19	Birth weight;	chr10:102961369	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs11191479	MIMAT0005951	hsa-miR-1307-3p	-3.8	0.00017	-0.17	-0.19	Birth weight;	chr10:102963863	chr10:103394301~103394322:-
BLCA	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-3.8	0.00017	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
BLCA	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-3.8	0.00017	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
BLCA	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-3.79	0.000172	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
BLCA	cis	rs12431410	0.782	rs10138093	MIMAT0022287	hsa-miR-5586-5p	-3.79	0.000173	-0.18	-0.19	Schizophrenia;	chr14:59704214	chr14:59646999~59647020:-
BLCA	cis	rs7035284	1	rs7028950	MIMAT0004504	hsa-miR-31-3p	-3.79	0.000175	-0.25	-0.19	Pediatric bone mineral content (radius);	chr9:21682261	chr9:21512121~21512142:-
BLCA	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	3.79	0.000175	0.16	0.19	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
BLCA	cis	rs950880	0.71	rs66566526	MIMAT0019927	hsa-miR-4772-3p	3.79	0.000177	0.17	0.19	Serum protein levels (sST2);	chr2:102431342	chr2:102432336~102432357:+
BLCA	cis	rs950880	0.71	rs56331791	MIMAT0019927	hsa-miR-4772-3p	3.79	0.000177	0.17	0.19	Serum protein levels (sST2);	chr2:102431697	chr2:102432336~102432357:+
BLCA	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-3.79	0.000177	-0.38	-0.19	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
BLCA	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-3.79	0.000177	-0.38	-0.19	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
BLCA	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000179	-0.15	-0.19	Asthma;	chr2:102379885	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000179	-0.15	-0.19	Asthma;	chr2:102381819	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000179	-0.15	-0.19	Asthma;	chr2:102382514	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000179	-0.15	-0.19	Asthma;	chr2:102382943	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000179	-0.15	-0.19	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000179	-0.15	-0.19	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
BLCA	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	3.78	0.00018	0.36	0.19	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
BLCA	cis	rs7851726	0.624	rs12347649	MIMAT0019208	hsa-miR-3074-5p	-3.78	0.00018	-0.15	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94901286	chr9:95086063~95086083:-
BLCA	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	3.78	0.000181	0.17	0.19	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	3.78	0.000182	0.16	0.19	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
BLCA	cis	rs74233809	1	rs34747231	MIMAT0005951	hsa-miR-1307-3p	-3.78	0.000182	-0.17	-0.19	Birth weight;	chr10:103182487	chr10:103394301~103394322:-
BLCA	cis	rs12431410	0.55	rs2350136	MIMAT0022287	hsa-miR-5586-5p	-3.78	0.000184	-0.17	-0.19	Schizophrenia;	chr14:59719780	chr14:59646999~59647020:-
BLCA	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-3.78	0.000186	-0.15	-0.19	Asthma;	chr2:102381261	chr2:102432336~102432357:+
BLCA	cis	rs7851726	0.585	rs7870160	MIMAT0019208	hsa-miR-3074-5p	-3.77	0.000187	-0.15	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94950249	chr9:95086063~95086083:-
BLCA	cis	rs12431410	0.892	rs12894153	MIMAT0022287	hsa-miR-5586-5p	3.77	0.000189	0.17	0.19	Schizophrenia;	chr14:59689975	chr14:59646999~59647020:-
BLCA	cis	rs1727638	0.569	rs1738071	MIMAT0004550	hsa-miR-30c-2-3p	3.77	0.00019	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71470773	chr6:71376964~71376985:-
BLCA	cis	rs1727638	0.592	rs1738070	MIMAT0004550	hsa-miR-30c-2-3p	3.77	0.00019	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71470775	chr6:71376964~71376985:-
BLCA	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000191	0.16	0.19	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
BLCA	cis	rs1727638	0.522	rs852923	MIMAT0004550	hsa-miR-30c-2-3p	3.77	0.000191	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71473384	chr6:71376964~71376985:-
BLCA	cis	rs1727638	0.522	rs10155718	MIMAT0004550	hsa-miR-30c-2-3p	3.77	0.000191	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71473481	chr6:71376964~71376985:-
BLCA	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-3.77	0.000191	-0.11	-0.19	Migraine;	chr10:103305652	chr10:103394301~103394322:-
BLCA	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000191	0.16	0.19	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000191	0.16	0.19	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000191	0.16	0.19	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	3.77	0.000191	0.16	0.19	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
BLCA	cis	rs3011225	0.697	rs3791054	MIMAT0027369	hsa-miR-6734-5p	-3.77	0.000192	-0.33	-0.19	Amyotrophic lateral sclerosis (age of onset);	chr1:43789609	chr1:43364688~43364710:-
BLCA	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-3.77	0.000193	-0.15	-0.19	Asthma;	chr2:102374753	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.892	rs1952035	MIMAT0022287	hsa-miR-5586-5p	3.76	0.000196	0.17	0.19	Schizophrenia;	chr14:59697383	chr14:59646999~59647020:-
BLCA	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	3.76	0.000197	0.16	0.19	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	3.76	0.000197	0.16	0.19	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
BLCA	cis	rs950880	0.71	rs4140785	MIMAT0019927	hsa-miR-4772-3p	3.76	0.000197	0.17	0.19	Serum protein levels (sST2);	chr2:102472057	chr2:102432336~102432357:+
BLCA	cis	rs7258177	1	rs7250307	MIMAT0000078	hsa-miR-23a-3p	-3.76	0.000197	-0.14	-0.19	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr19:13689895	chr19:13836595~13836615:-
BLCA	cis	rs250677	0.687	rs250673	MIMAT0022708	hsa-miR-584-3p	3.76	0.000198	0.26	0.19	Breast cancer;	chr5:149066235	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.687	rs250672	MIMAT0022708	hsa-miR-584-3p	3.76	0.000198	0.26	0.19	Breast cancer;	chr5:149066547	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.687	rs250671	MIMAT0022708	hsa-miR-584-3p	3.76	0.000198	0.26	0.19	Breast cancer;	chr5:149066960	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.652	rs250670	MIMAT0022708	hsa-miR-584-3p	3.76	0.000198	0.26	0.19	Breast cancer;	chr5:149067083	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.687	rs168750	MIMAT0022708	hsa-miR-584-3p	3.76	0.000198	0.26	0.19	Breast cancer;	chr5:149067193	chr5:149062334~149062355:-
BLCA	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-3.76	0.000198	-0.23	-0.19	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
BLCA	cis	rs7072216	0.77	rs7909131	MIMAT0026738	hsa-miR-1287-3p	3.76	0.000199	0.15	0.19	Metabolite levels;	chr10:98411714	chr10:98395232~98395253:-
BLCA	cis	rs17214007	0.877	rs2075514	MIMAT0002174	hsa-miR-484	3.76	0.000201	0.21	0.19	Cognitive function;	chr16:15778752	chr16:15643301~15643322:+
BLCA	cis	rs17214007	0.877	rs11644832	MIMAT0002174	hsa-miR-484	3.76	0.000201	0.21	0.19	Cognitive function;	chr16:15778891	chr16:15643301~15643322:+
BLCA	cis	rs17214007	0.877	rs11645883	MIMAT0002174	hsa-miR-484	3.76	0.000201	0.21	0.19	Cognitive function;	chr16:15778950	chr16:15643301~15643322:+
BLCA	cis	rs12431410	0.584	rs10143626	MIMAT0022287	hsa-miR-5586-5p	-3.75	0.000201	-0.17	-0.19	Schizophrenia;	chr14:59779264	chr14:59646999~59647020:-
BLCA	cis	rs6575793	0.967	rs4076891	MIMAT0002172	hsa-miR-376b-3p	-3.75	0.000202	-0.14	-0.19	Menarche (age at onset);	chr14:100570487	chr14:101040497~101040518:+
BLCA	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000203	-0.15	-0.19	Asthma;	chr2:102412435	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000203	-0.15	-0.19	Asthma;	chr2:102412461	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000203	-0.15	-0.19	Asthma;	chr2:102412524	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.615	rs8011025	MIMAT0022287	hsa-miR-5586-5p	-3.75	0.000203	-0.17	-0.19	Schizophrenia;	chr14:59634009	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.578	rs8011640	MIMAT0022287	hsa-miR-5586-5p	-3.75	0.000203	-0.17	-0.19	Schizophrenia;	chr14:59634141	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.578	rs4898998	MIMAT0022287	hsa-miR-5586-5p	-3.75	0.000203	-0.17	-0.19	Schizophrenia;	chr14:59634249	chr14:59646999~59647020:-
BLCA	cis	rs12431410	0.615	rs8022717	MIMAT0022287	hsa-miR-5586-5p	-3.75	0.000203	-0.17	-0.19	Schizophrenia;	chr14:59644503	chr14:59646999~59647020:-
BLCA	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	3.75	0.000203	0.17	0.19	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs17115213	MIMAT0005951	hsa-miR-1307-3p	-3.75	0.000203	-0.17	-0.19	Birth weight;	chr10:102921386	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs12411886	MIMAT0005951	hsa-miR-1307-3p	-3.75	0.000203	-0.17	-0.19	Birth weight;	chr10:102925542	chr10:103394301~103394322:-
BLCA	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000204	-0.15	-0.19	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000204	-0.15	-0.19	Asthma;	chr2:102388870	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000204	-0.15	-0.19	Asthma;	chr2:102389644	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000204	-0.15	-0.19	Asthma;	chr2:102389988	chr2:102432336~102432357:+
BLCA	cis	rs6558174	0.863	rs17746902	MIMAT0000510	hsa-miR-320a-3p	-3.75	0.000205	-0.17	-0.19	Breast cancer;	chr8:22634467	chr8:22244975~22244996:-
BLCA	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000206	-0.15	-0.19	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000206	-0.15	-0.19	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.615	rs12586787	MIMAT0022287	hsa-miR-5586-5p	-3.75	0.000207	-0.17	-0.19	Schizophrenia;	chr14:59645850	chr14:59646999~59647020:-
BLCA	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	3.75	0.000208	0.16	0.19	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	3.75	0.000208	0.16	0.19	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
BLCA	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-3.75	0.000208	-0.15	-0.19	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.691	rs10786419	MIMAT0026738	hsa-miR-1287-3p	3.74	0.000209	0.15	0.19	Metabolite levels;	chr10:98421183	chr10:98395232~98395253:-
BLCA	cis	rs12712133	0.552	rs1115281	MIMAT0019927	hsa-miR-4772-3p	3.74	0.000209	0.17	0.19	Primary biliary cholangitis;	chr2:102274647	chr2:102432336~102432357:+
BLCA	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-3.74	0.000209	-0.28	-0.19	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
BLCA	cis	rs950880	0.71	rs11678975	MIMAT0019927	hsa-miR-4772-3p	3.74	0.00021	0.17	0.19	Serum protein levels (sST2);	chr2:102427279	chr2:102432336~102432357:+
BLCA	cis	rs1727638	0.743	rs199639	MIMAT0000088	hsa-miR-30a-3p	3.74	0.00021	0.21	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71526745	chr6:71403554~71403575:-
BLCA	cis	rs250677	1	rs36079	MIMAT0022708	hsa-miR-584-3p	3.74	0.00021	0.24	0.19	Breast cancer;	chr5:149050941	chr5:149062334~149062355:-
BLCA	cis	rs12431410	0.615	rs7143836	MIMAT0022287	hsa-miR-5586-5p	-3.74	0.000212	-0.17	-0.19	Schizophrenia;	chr14:59657864	chr14:59646999~59647020:-
BLCA	cis	rs7594645	0.59	rs61258471	MIMAT0014995	hsa-miR-3130-5p	3.74	0.000213	0.33	0.19	Episodic memory;	chr2:206751133	chr2:206783276~206783296:-
BLCA	cis	rs7594645	0.59	rs61258471	MIMAT0014995_1	hsa-miR-3130-5p	3.74	0.000213	0.33	0.19	Episodic memory;	chr2:206751133	chr2:206783246~206783266:+
BLCA	cis	rs7594645	0.59	rs73068058	MIMAT0014995	hsa-miR-3130-5p	3.74	0.000213	0.33	0.19	Episodic memory;	chr2:206752613	chr2:206783276~206783296:-
BLCA	cis	rs7594645	0.59	rs73068058	MIMAT0014995_1	hsa-miR-3130-5p	3.74	0.000213	0.33	0.19	Episodic memory;	chr2:206752613	chr2:206783246~206783266:+
BLCA	cis	rs6537837	0.668	rs12044778	MIMAT0000227	hsa-miR-197-3p	-3.74	0.000213	-0.15	-0.19	Major depressive disorder;	chr1:109541786	chr1:109598940~109598961:+
BLCA	cis	rs9807989	0.507	rs3732124	MIMAT0019927	hsa-miR-4772-3p	3.74	0.000214	0.15	0.19	Asthma;	chr2:102401592	chr2:102432336~102432357:+
BLCA	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-3.74	0.000214	-0.12	-0.19	Migraine;	chr10:103299551	chr10:103394341~103394361:-
BLCA	cis	rs7258177	1	rs2419952	MIMAT0000078	hsa-miR-23a-3p	-3.74	0.000215	-0.13	-0.19	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr19:13690527	chr19:13836595~13836615:-
BLCA	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	3.74	0.000217	0.16	0.19	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.536	rs2094058	MIMAT0022287	hsa-miR-5586-5p	3.73	0.000217	0.18	0.19	Schizophrenia;	chr14:59686837	chr14:59646999~59647020:-
BLCA	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	3.73	0.00022	0.16	0.19	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	3.73	0.00022	0.16	0.19	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
BLCA	cis	rs250677	0.652	rs250680	MIMAT0022708	hsa-miR-584-3p	3.73	0.00022	0.25	0.19	Breast cancer;	chr5:149056461	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.687	rs3095947	MIMAT0022708	hsa-miR-584-3p	3.73	0.00022	0.25	0.19	Breast cancer;	chr5:149057165	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.687	rs2963484	MIMAT0022708	hsa-miR-584-3p	3.73	0.00022	0.26	0.19	Breast cancer;	chr5:149071564	chr5:149062334~149062355:-
BLCA	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	3.73	0.000224	0.16	0.19	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.536	rs7159851	MIMAT0022287	hsa-miR-5586-5p	3.72	0.000226	0.19	0.19	Schizophrenia;	chr14:59687050	chr14:59646999~59647020:-
BLCA	cis	rs1727638	0.747	rs852964	MIMAT0004550	hsa-miR-30c-2-3p	3.72	0.000227	0.21	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71413926	chr6:71376964~71376985:-
BLCA	cis	rs7224314	1	rs57672368	MIMAT0003323	hsa-miR-548d-3p	-3.72	0.000227	-0.24	-0.19	Diisocyanate-induced asthma;	chr17:67362572	chr17:67471504~67471525:-
BLCA	cis	rs7224314	1	rs57672368	MIMAT0003323_1	hsa-miR-548d-3p	-3.72	0.000227	-0.24	-0.19	Diisocyanate-induced asthma;	chr17:67362572	chr8:123348049~123348070:-
BLCA	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	3.72	0.000228	0.15	0.19	Asthma;	chr2:102374328	chr2:102432336~102432357:+
BLCA	cis	rs12431410	0.892	rs727690	MIMAT0022287	hsa-miR-5586-5p	-3.72	0.000228	-0.17	-0.19	Schizophrenia;	chr14:59690642	chr14:59646999~59647020:-
BLCA	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-3.72	0.000229	-0.12	-0.19	Migraine;	chr10:103309363	chr10:103394341~103394361:-
BLCA	cis	rs7224314	1	rs62085808	MIMAT0003323	hsa-miR-548d-3p	-3.72	0.000231	-0.24	-0.19	Diisocyanate-induced asthma;	chr17:67361576	chr17:67471504~67471525:-
BLCA	cis	rs7224314	1	rs62085808	MIMAT0003323_1	hsa-miR-548d-3p	-3.72	0.000231	-0.24	-0.19	Diisocyanate-induced asthma;	chr17:67361576	chr8:123348049~123348070:-
BLCA	cis	rs1727638	0.743	rs199639	MIMAT0000087	hsa-miR-30a-5p	3.72	0.000232	0.21	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71526745	chr6:71403595~71403616:-
BLCA	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	3.72	0.000232	0.15	0.19	Asthma;	chr2:102393077	chr2:102432336~102432357:+
BLCA	cis	rs3011225	0.697	rs3791061	MIMAT0027369	hsa-miR-6734-5p	-3.72	0.000232	-0.33	-0.19	Amyotrophic lateral sclerosis (age of onset);	chr1:43813378	chr1:43364688~43364710:-
BLCA	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-3.72	0.000233	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
BLCA	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-3.72	0.000233	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
BLCA	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-3.72	0.000233	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
BLCA	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-3.72	0.000233	-0.21	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
BLCA	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	3.72	0.000234	0.21	0.19	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
BLCA	cis	rs2302612	0.687	rs3755285	MIMAT0019927	hsa-miR-4772-3p	-3.71	0.000235	-0.16	-0.19	Serum protein levels (sST2);	chr2:102227560	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs11191580	MIMAT0005951	hsa-miR-1307-3p	3.71	0.000235	0.17	0.19	Birth weight;	chr10:103146454	chr10:103394301~103394322:-
BLCA	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000235	0.16	0.19	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
BLCA	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-3.71	0.000238	-0.39	-0.19	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
BLCA	cis	rs1727638	0.522	rs852926	MIMAT0004550	hsa-miR-30c-2-3p	3.71	0.000238	0.22	0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71471770	chr6:71376964~71376985:-
BLCA	cis	rs9807989	0.507	rs4479442	MIMAT0019927	hsa-miR-4772-3p	-3.71	0.00024	-0.15	-0.19	Asthma;	chr2:102437614	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000241	0.16	0.19	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000241	0.16	0.19	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000241	0.16	0.19	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000241	0.16	0.19	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
BLCA	cis	rs6558174	0.965	rs6558172	MIMAT0000510	hsa-miR-320a-3p	3.71	0.000241	0.17	0.19	Breast cancer;	chr8:22634539	chr8:22244975~22244996:-
BLCA	cis	rs7649443	0.759	rs7624684	MIMAT0019973	hsa-miR-4797-3p	3.71	0.000241	0.24	0.19	Nonsyndromic cleft lip with cleft palate;	chr3:197244290	chr3:197293888~197293908:-
BLCA	cis	rs250677	0.687	rs2915809	MIMAT0022708	hsa-miR-584-3p	3.71	0.000242	0.26	0.19	Breast cancer;	chr5:149072548	chr5:149062334~149062355:-
BLCA	cis	rs250677	0.687	rs250663	MIMAT0022708	hsa-miR-584-3p	3.71	0.000242	0.26	0.19	Breast cancer;	chr5:149073554	chr5:149062334~149062355:-
BLCA	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000242	0.15	0.19	Asthma;	chr2:102374909	chr2:102432336~102432357:+
BLCA	cis	rs74233809	1	rs12219027	MIMAT0005951	hsa-miR-1307-3p	-3.71	0.000243	-0.17	-0.19	Birth weight;	chr10:103051446	chr10:103394301~103394322:-
BLCA	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	3.7	0.000244	0.35	0.19	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
BLCA	cis	rs32576	0.74	rs26124	MIMAT0000732	hsa-miR-378a-3p	-3.7	0.000246	-0.18	-0.19	Obesity-related traits;	chr5:149849085	chr5:149732867~149732888:+
BLCA	cis	rs7210990	0.766	rs2779211	MIMAT0005942	hsa-miR-1288-3p	-3.7	0.000246	-0.19	-0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15972621	chr17:16282058~16282078:+
BLCA	cis	rs17730929	0.659	rs1033095	MIMAT0005923	hsa-miR-1269a	3.7	0.000247	0.43	0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66366293	chr4:66276890~66276911:+
BLCA	cis	rs4988958	0.565	rs885088	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000247	-0.15	-0.19	Asthma (childhood onset);	chr2:102422584	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000247	-0.15	-0.19	Asthma;	chr2:102426252	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000247	-0.15	-0.19	Asthma;	chr2:102427407	chr2:102432336~102432357:+
BLCA	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000247	-0.15	-0.19	Asthma;	chr2:102427715	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000247	-0.15	-0.19	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
BLCA	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-3.7	0.000247	-0.15	-0.19	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-3.7	0.000248	-0.16	-0.19	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
BLCA	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-3.7	0.000248	-0.12	-0.19	Migraine;	chr10:103317367	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-3.7	0.000248	-0.12	-0.19	Migraine;	chr10:103319682	chr10:103394341~103394361:-
BLCA	cis	rs1057510	0.79	rs16932801	MIMAT0000617	hsa-miR-200c-3p	3.7	0.000248	0.14	0.19	Myopia (pathological);	chr12:6611216	chr12:6963742~6963764:+
BLCA	cis	rs12431410	0.857	rs12434368	MIMAT0022287	hsa-miR-5586-5p	3.7	0.000249	0.17	0.19	Schizophrenia;	chr14:59696125	chr14:59646999~59647020:-
BLCA	cis	rs6537837	0.701	rs17595368	MIMAT0000227	hsa-miR-197-3p	-3.7	0.000251	-0.17	-0.19	Major depressive disorder;	chr1:109611768	chr1:109598940~109598961:+
BLCA	cis	rs6537837	0.701	rs6680537	MIMAT0000227	hsa-miR-197-3p	-3.7	0.000251	-0.17	-0.19	Major depressive disorder;	chr1:109612400	chr1:109598940~109598961:+
BLCA	cis	rs950880	0.71	rs4851582	MIMAT0019927	hsa-miR-4772-3p	3.7	0.000251	0.17	0.19	Serum protein levels (sST2);	chr2:102435098	chr2:102432336~102432357:+
BLCA	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	3.7	0.000253	0.21	0.19	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
BLCA	cis	rs74233809	1	rs11191519	MIMAT0005951	hsa-miR-1307-3p	-3.69	0.000256	-0.17	-0.19	Birth weight;	chr10:103025161	chr10:103394301~103394322:-
BLCA	cis	rs6558174	0.93	rs12676084	MIMAT0000510	hsa-miR-320a-3p	3.69	0.000258	0.17	0.19	Breast cancer;	chr8:22635837	chr8:22244975~22244996:-
BLCA	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-3.69	0.000258	-0.11	-0.19	Migraine;	chr10:103299082	chr10:103394301~103394322:-
BLCA	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	3.69	0.000262	0.16	0.19	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.584	rs7140886	MIMAT0022287	hsa-miR-5586-5p	3.69	0.000262	0.17	0.19	Schizophrenia;	chr14:59778295	chr14:59646999~59647020:-
BLCA	cis	rs74233809	1	rs11191514	MIMAT0005951	hsa-miR-1307-3p	-3.68	0.000262	-0.16	-0.19	Birth weight;	chr10:103013607	chr10:103394301~103394322:-
BLCA	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-3.68	0.000264	-0.12	-0.19	Migraine;	chr10:103293183	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-3.68	0.000264	-0.12	-0.19	Migraine;	chr10:103293219	chr10:103394341~103394361:-
BLCA	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	3.68	0.000265	0.12	0.19	Migraine;	chr10:103347713	chr10:103394341~103394361:-
BLCA	cis	rs854765	0.647	rs2974998	MIMAT0004811	hsa-miR-33b-3p	-3.68	0.000268	-0.19	-0.19	Total body bone mineral density;	chr17:18092305	chr17:17813857~17813878:-
BLCA	cis	rs12431410	0.892	rs1957988	MIMAT0022287	hsa-miR-5586-5p	3.68	0.000269	0.17	0.19	Schizophrenia;	chr14:59693061	chr14:59646999~59647020:-
BLCA	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	3.68	0.000269	0.16	0.19	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
BLCA	cis	rs632111	0.519	rs281380	MIMAT0000451	hsa-miR-150-5p	3.68	0.000269	0.14	0.19	Serum lipase activity;	chr19:48711213	chr19:49500832~49500853:-
BLCA	cis	rs32576	0.74	rs32574	MIMAT0000732	hsa-miR-378a-3p	-3.68	0.00027	-0.17	-0.19	Obesity-related traits;	chr5:149839323	chr5:149732867~149732888:+
BLCA	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	3.68	0.00027	0.16	0.19	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	3.68	0.00027	0.2	0.19	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	3.68	0.00027	0.2	0.19	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	3.68	0.000271	0.2	0.19	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
BLCA	cis	rs12431410	0.892	rs1957989	MIMAT0022287	hsa-miR-5586-5p	3.68	0.000272	0.17	0.19	Schizophrenia;	chr14:59694436	chr14:59646999~59647020:-
BLCA	cis	rs1727638	0.522	rs852928	MIMAT0004550	hsa-miR-30c-2-3p	-3.67	0.000273	-0.21	-0.19	Cerebrospinal fluid AB1-42 levels;	chr6:71471412	chr6:71376964~71376985:-
BLCA	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000273	0.2	0.19	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-3.67	0.000274	-0.2	-0.19	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
BLCA	cis	rs74233809	1	rs77787671	MIMAT0005951	hsa-miR-1307-3p	-3.67	0.000276	-0.16	-0.19	Birth weight;	chr10:103016448	chr10:103394301~103394322:-
BLCA	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	3.67	0.00028	0.16	0.19	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000282	0.2	0.19	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000282	0.2	0.19	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000282	0.2	0.19	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000282	0.2	0.19	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000282	0.2	0.19	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000283	0.2	0.19	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000283	0.2	0.19	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000283	0.2	0.19	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	3.67	0.000283	0.2	0.19	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
BLCA	cis	rs7594645	0.59	rs2359724	MIMAT0014995	hsa-miR-3130-5p	-3.66	0.000284	-0.32	-0.19	Episodic memory;	chr2:206750798	chr2:206783276~206783296:-
BLCA	cis	rs7594645	0.59	rs2359724	MIMAT0014995_1	hsa-miR-3130-5p	-3.66	0.000284	-0.32	-0.19	Episodic memory;	chr2:206750798	chr2:206783246~206783266:+
BLCA	cis	rs12431410	1	rs12431410	MIMAT0022287	hsa-miR-5586-5p	3.66	0.000284	0.17	0.19	Schizophrenia;	chr14:59699304	chr14:59646999~59647020:-
BLCA	cis	rs2069426	0.73	rs115939893	MIMAT0000089	hsa-miR-31-5p	-3.66	0.000285	-0.36	-0.19	Acute lymphoblastic leukemia (childhood);	chr9:22054822	chr9:21512158~21512178:-
BLCA	cis	rs12542922	0.867	rs12547023	MIMAT0017987	hsa-miR-3610	-3.66	0.000287	-0.41	-0.19	Asthma;	chr8:116319626	chr8:116874740~116874759:-
BLCA	cis	rs950880	0.71	rs11681718	MIMAT0019927	hsa-miR-4772-3p	3.66	0.000289	0.17	0.19	Serum protein levels (sST2);	chr2:102434684	chr2:102432336~102432357:+
BLCA	cis	rs7258177	1	rs16979304	MIMAT0000078	hsa-miR-23a-3p	-3.66	0.00029	-0.13	-0.19	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid);	chr19:13689594	chr19:13836595~13836615:-
BLCA	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-3.66	0.00029	-0.27	-0.19	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
BLCA	cis	rs17730929	0.722	rs13101728	MIMAT0005923	hsa-miR-1269a	-3.66	0.000291	-0.54	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66289547	chr4:66276890~66276911:+
BLCA	cis	rs17730929	0.656	rs61224431	MIMAT0005923	hsa-miR-1269a	-3.66	0.000291	-0.54	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66290047	chr4:66276890~66276911:+
BLCA	cis	rs17730929	0.722	rs67668930	MIMAT0005923	hsa-miR-1269a	-3.66	0.000291	-0.54	-0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66290585	chr4:66276890~66276911:+
BLCA	cis	rs12431410	0.55	rs10131474	MIMAT0022287	hsa-miR-5586-5p	-3.66	0.000293	-0.17	-0.19	Schizophrenia;	chr14:59712557	chr14:59646999~59647020:-
BLCA	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	3.65	0.000294	0.16	0.19	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	3.65	0.000294	0.16	0.19	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	3.65	0.000294	0.16	0.19	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	3.65	0.000294	0.16	0.19	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	3.65	0.000294	0.16	0.19	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
BLCA	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
BLCA	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	3.65	0.000298	0.2	0.19	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
BLCA	cis	rs74233809	1	rs74444347	MIMAT0005951	hsa-miR-1307-3p	-3.65	3e-04	-0.16	-0.19	Birth weight;	chr10:103009518	chr10:103394301~103394322:-
BLCA	cis	rs74233809	1	rs12221335	MIMAT0005951	hsa-miR-1307-3p	-3.65	3e-04	-0.16	-0.19	Birth weight;	chr10:103009635	chr10:103394301~103394322:-
BLCA	cis	rs7072216	0.652	rs11189600	MIMAT0026738	hsa-miR-1287-3p	-3.65	3e-04	-0.15	-0.19	Metabolite levels;	chr10:98419517	chr10:98395232~98395253:-
BLCA	cis	rs74233809	1	rs76752100	MIMAT0005951	hsa-miR-1307-3p	-3.65	0.000304	-0.16	-0.19	Birth weight;	chr10:103034329	chr10:103394301~103394322:-
BLCA	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	3.65	0.000304	0.16	0.19	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
BLCA	cis	rs12431410	0.615	rs8005453	MIMAT0022287	hsa-miR-5586-5p	-3.64	0.000306	-0.16	-0.18	Schizophrenia;	chr14:59669814	chr14:59646999~59647020:-
BLCA	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-3.64	0.000306	-0.22	-0.18	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
BLCA	cis	rs74233809	1	rs12219304	MIMAT0005951	hsa-miR-1307-3p	-3.64	0.000308	-0.17	-0.18	Birth weight;	chr10:103171827	chr10:103394301~103394322:-
BLCA	cis	rs1359742	0.846	rs3903983	MIMAT0000089	hsa-miR-31-5p	3.64	0.000309	0.21	0.18	Chronic lymphocytic leukemia;	chr9:22342374	chr9:21512158~21512178:-
BLCA	cis	rs6537837	0.838	rs12046010	MIMAT0000227	hsa-miR-197-3p	-3.64	0.00031	-0.15	-0.18	Major depressive disorder;	chr1:109561567	chr1:109598940~109598961:+
BLCA	cis	rs9900280	1	rs8081267	MIMAT0019061	hsa-miR-4523	3.64	0.000313	0.21	0.18	Mean platelet volume;	chr17:29436892	chr17:29390668~29390688:+
BLCA	cis	rs7851726	0.69	rs10739982	MIMAT0019208	hsa-miR-3074-5p	-3.64	0.000315	-0.15	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94763966	chr9:95086063~95086083:-
BLCA	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-3.64	0.000316	-0.12	-0.18	Migraine;	chr10:103273258	chr10:103394341~103394361:-
BLCA	cis	rs9807989	0.507	rs1420105	MIMAT0019927	hsa-miR-4772-3p	-3.63	0.000319	-0.15	-0.18	Asthma;	chr2:102418659	chr2:102432336~102432357:+
BLCA	cis	rs153750	0.564	rs254959	MIMAT0018186	hsa-miR-3912-3p	3.63	0.000319	0.24	0.18	Height;	chr5:171799083	chr5:171386678~171386698:-
BLCA	cis	rs32579	0.657	rs32581	MIMAT0000732	hsa-miR-378a-3p	3.63	0.00032	0.15	0.18	Tanning;	chr5:149826067	chr5:149732867~149732888:+
BLCA	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-3.63	0.00032	-0.26	-0.18	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
BLCA	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	3.63	0.000322	0.2	0.18	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
BLCA	cis	rs6537837	0.701	rs12021920	MIMAT0000227	hsa-miR-197-3p	-3.63	0.000322	-0.17	-0.18	Major depressive disorder;	chr1:109604665	chr1:109598940~109598961:+
BLCA	cis	rs7868228	1	rs7868228	MIMAT0004504	hsa-miR-31-3p	3.63	0.000322	0.26	0.18	Gut microbiome composition (winter);	chr9:21667763	chr9:21512121~21512142:-
BLCA	cis	rs6537837	0.838	rs12023950	MIMAT0000227	hsa-miR-197-3p	-3.63	0.000324	-0.15	-0.18	Major depressive disorder;	chr1:109557236	chr1:109598940~109598961:+
BLCA	cis	rs32576	0.74	rs26127	MIMAT0000732	hsa-miR-378a-3p	3.63	0.000324	0.17	0.18	Obesity-related traits;	chr5:149842225	chr5:149732867~149732888:+
BLCA	cis	rs4253772	0.55	rs6007823	MIMAT0000063	hsa-let-7b-5p	-3.63	0.000325	-0.32	-0.18	Cholesterol, total;LDL cholesterol;	chr22:46310352	chr22:46113691~46113712:+
BLCA	cis	rs6537837	0.642	rs6658641	MIMAT0000227	hsa-miR-197-3p	-3.63	0.000326	-0.17	-0.18	Major depressive disorder;	chr1:109610576	chr1:109598940~109598961:+
BLCA	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	3.63	0.000327	0.2	0.18	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
BLCA	cis	rs74233809	1	rs732998	MIMAT0005951	hsa-miR-1307-3p	3.63	0.000328	0.16	0.18	Birth weight;	chr10:103138144	chr10:103394301~103394322:-
BLCA	cis	rs1727638	0.522	rs701698	MIMAT0004550	hsa-miR-30c-2-3p	3.63	0.000328	0.21	0.18	Cerebrospinal fluid AB1-42 levels;	chr6:71469415	chr6:71376964~71376985:-
BLCA	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-3.62	0.00033	-0.21	-0.18	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
BLCA	cis	rs7828089	0.542	rs7332050	MIMAT0000510	hsa-miR-320a-3p	-3.62	0.000333	-0.18	-0.18	Verbal declarative memory;	chr8:22407781	chr8:22244975~22244996:-
BLCA	trans	rs11119805	0.649	rs11119816	MIMAT0018187	hsa-miR-3913-5p	6.06	3.27e-09	0.46	0.3	Stearic acid (18:0) levels;	chr1:211826146	chr12:69584780~69584801:-
BLCA	trans	rs11119805	0.649	rs11119816	MIMAT0018187_1	hsa-miR-3913-5p	6.06	3.27e-09	0.46	0.3	Stearic acid (18:0) levels;	chr1:211826146	chr12:69584744~69584765:+
BLCA	trans	rs806215	0.547	rs9791922	MIMAT0006764	hsa-miR-320d	5.98	5.26e-09	0.35	0.29	Type 2 diabetes;	chr7:127919080	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs9791922	MIMAT0006764_1	hsa-miR-320d	5.98	5.26e-09	0.35	0.29	Type 2 diabetes;	chr7:127919080	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs12539411	MIMAT0006764	hsa-miR-320d	5.95	6.16e-09	0.35	0.29	Type 2 diabetes;	chr7:127828875	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs12539411	MIMAT0006764_1	hsa-miR-320d	5.95	6.16e-09	0.35	0.29	Type 2 diabetes;	chr7:127828875	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs3808086	MIMAT0006764	hsa-miR-320d	5.93	7.04e-09	0.35	0.29	Type 2 diabetes;	chr7:127899192	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs3808086	MIMAT0006764_1	hsa-miR-320d	5.93	7.04e-09	0.35	0.29	Type 2 diabetes;	chr7:127899192	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.666	rs12672945	MIMAT0006764	hsa-miR-320d	5.91	7.85e-09	0.37	0.29	Type 2 diabetes;	chr7:127870436	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.666	rs12672945	MIMAT0006764_1	hsa-miR-320d	5.91	7.85e-09	0.37	0.29	Type 2 diabetes;	chr7:127870436	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs11768841	MIMAT0006764	hsa-miR-320d	5.85	1.09e-08	0.35	0.29	Type 2 diabetes;	chr7:127911350	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs11768841	MIMAT0006764_1	hsa-miR-320d	5.85	1.09e-08	0.35	0.29	Type 2 diabetes;	chr7:127911350	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.813	rs806175	MIMAT0006764	hsa-miR-320d	-5.78	1.58e-08	-0.37	-0.29	Type 2 diabetes;	chr7:127649381	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.813	rs806175	MIMAT0006764_1	hsa-miR-320d	-5.78	1.58e-08	-0.37	-0.29	Type 2 diabetes;	chr7:127649381	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs12673293	MIMAT0006764	hsa-miR-320d	5.77	1.64e-08	0.34	0.29	Type 2 diabetes;	chr7:127880109	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs12673293	MIMAT0006764_1	hsa-miR-320d	5.77	1.64e-08	0.34	0.29	Type 2 diabetes;	chr7:127880109	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs3808088	MIMAT0006764	hsa-miR-320d	5.77	1.64e-08	0.34	0.29	Type 2 diabetes;	chr7:127885985	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs3808088	MIMAT0006764_1	hsa-miR-320d	5.77	1.64e-08	0.34	0.29	Type 2 diabetes;	chr7:127885985	chrX:140926172~140926190:-
BLCA	trans	rs11726248	1	rs76587904	MIMAT0004482	hsa-let-7b-3p	-5.76	1.72e-08	-0.5	-0.29	Thyroid hormone levels;	chr4:170106939	chr22:46113745~46113766:+
BLCA	trans	rs806215	0.526	rs3757780	MIMAT0006764	hsa-miR-320d	5.76	1.76e-08	0.34	0.29	Type 2 diabetes;	chr7:127795466	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs3757780	MIMAT0006764_1	hsa-miR-320d	5.76	1.76e-08	0.34	0.29	Type 2 diabetes;	chr7:127795466	chrX:140926172~140926190:-
BLCA	trans	rs1957895	0.522	rs8010132	MIMAT0003386	hsa-miR-376a-5p	-5.75	1.9e-08	-0.45	-0.28	Rheumatoid arthritis;	chr14:61469599	chr14:101040788~101040809:+
BLCA	trans	rs6693882	0.967	rs6688538	MIMAT0009196	hsa-miR-103a-2-5p	-5.74	1.97e-08	-0.21	-0.28	Pain;	chr1:95679787	chr20:3917504~3917526:+
BLCA	trans	rs1957895	0.522	rs11158348	MIMAT0003386	hsa-miR-376a-5p	-5.74	1.98e-08	-0.45	-0.28	Rheumatoid arthritis;	chr14:61469202	chr14:101040788~101040809:+
BLCA	trans	rs7193263	0.642	rs6500769	MIMAT0000420	hsa-miR-30b-5p	-5.73	2.03e-08	-0.3	-0.28	Depressive symptoms (multi-trait analysis);	chr16:6293978	chr8:134800570~134800591:-
BLCA	trans	rs806215	0.666	rs3757771	MIMAT0006764	hsa-miR-320d	-5.72	2.13e-08	-0.35	-0.28	Type 2 diabetes;	chr7:127898506	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.666	rs3757771	MIMAT0006764_1	hsa-miR-320d	-5.72	2.13e-08	-0.35	-0.28	Type 2 diabetes;	chr7:127898506	chrX:140926172~140926190:-
BLCA	trans	rs78411870	0.915	rs11192997	MIMAT0019208	hsa-miR-3074-5p	-5.72	2.14e-08	-0.42	-0.28	Stromal-cell-derived factor 1 alpha levels;	chr10:106650584	chr9:95086063~95086083:-
BLCA	trans	rs806215	0.526	rs62481450	MIMAT0006764	hsa-miR-320d	5.72	2.19e-08	0.34	0.28	Type 2 diabetes;	chr7:127928930	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs62481450	MIMAT0006764_1	hsa-miR-320d	5.72	2.19e-08	0.34	0.28	Type 2 diabetes;	chr7:127928930	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs3824003	MIMAT0006764	hsa-miR-320d	5.7	2.37e-08	0.33	0.28	Type 2 diabetes;	chr7:127829571	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs3824003	MIMAT0006764_1	hsa-miR-320d	5.7	2.37e-08	0.33	0.28	Type 2 diabetes;	chr7:127829571	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs3757778	MIMAT0006764	hsa-miR-320d	5.7	2.43e-08	0.33	0.28	Type 2 diabetes;	chr7:127816553	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs3757778	MIMAT0006764_1	hsa-miR-320d	5.7	2.43e-08	0.33	0.28	Type 2 diabetes;	chr7:127816553	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs62481419	MIMAT0006764	hsa-miR-320d	5.68	2.66e-08	0.33	0.28	Type 2 diabetes;	chr7:127847954	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs62481419	MIMAT0006764_1	hsa-miR-320d	5.68	2.66e-08	0.33	0.28	Type 2 diabetes;	chr7:127847954	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs58106688	MIMAT0006764	hsa-miR-320d	5.68	2.73e-08	0.33	0.28	Type 2 diabetes;	chr7:127843158	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs58106688	MIMAT0006764_1	hsa-miR-320d	5.68	2.73e-08	0.33	0.28	Type 2 diabetes;	chr7:127843158	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs62481416	MIMAT0006764	hsa-miR-320d	5.68	2.74e-08	0.33	0.28	Type 2 diabetes;	chr7:127838072	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs62481416	MIMAT0006764_1	hsa-miR-320d	5.68	2.74e-08	0.33	0.28	Type 2 diabetes;	chr7:127838072	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs1419967	MIMAT0006764	hsa-miR-320d	5.68	2.74e-08	0.33	0.28	Type 2 diabetes;	chr7:127834382	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs1419967	MIMAT0006764_1	hsa-miR-320d	5.68	2.74e-08	0.33	0.28	Type 2 diabetes;	chr7:127834382	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs12668077	MIMAT0006764	hsa-miR-320d	5.68	2.74e-08	0.33	0.28	Type 2 diabetes;	chr7:127836200	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs12668077	MIMAT0006764_1	hsa-miR-320d	5.68	2.74e-08	0.33	0.28	Type 2 diabetes;	chr7:127836200	chrX:140926172~140926190:-
BLCA	trans	rs6693882	0.903	rs1509181	MIMAT0009196	hsa-miR-103a-2-5p	-5.67	2.88e-08	-0.21	-0.28	Pain;	chr1:95681226	chr20:3917504~3917526:+
BLCA	trans	rs806215	0.547	rs62481385	MIMAT0006764	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127770657	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs62481385	MIMAT0006764_1	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127770657	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs765971	MIMAT0006764	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127780588	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs765971	MIMAT0006764_1	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127780588	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs59140894	MIMAT0006764	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127790743	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs59140894	MIMAT0006764_1	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127790743	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.526	rs2402871	MIMAT0006764	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127799465	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.526	rs2402871	MIMAT0006764_1	hsa-miR-320d	5.66	2.94e-08	0.33	0.28	Type 2 diabetes;	chr7:127799465	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs11772303	MIMAT0006764	hsa-miR-320d	5.66	2.94e-08	0.34	0.28	Type 2 diabetes;	chr7:127758908	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs11772303	MIMAT0006764_1	hsa-miR-320d	5.66	2.94e-08	0.34	0.28	Type 2 diabetes;	chr7:127758908	chrX:140926172~140926190:-
BLCA	trans	rs806215	0.547	rs10487497	MIMAT0006764	hsa-miR-320d	-5.66	2.97e-08	-0.33	-0.28	Type 2 diabetes;	chr7:127760613	chr13:40727828~40727846:-
BLCA	trans	rs806215	0.547	rs10487497	MIMAT0006764_1	hsa-miR-320d	-5.66	2.97e-08	-0.33	-0.28	Type 2 diabetes;	chr7:127760613	chrX:140926172~140926190:-